Case Record by Swetha Raghavan,
EFFECT OF MIRABILIS JALAPALINNON REPRODUCTIVE SYSTEM OF MALE 
ANDFEMALE WISTAR RATS-A FOCUS ON ANTIFERTILITY EFFICACY 
 
 
THESIS 
 
 
 
Submitted to 
The TamilnaduDr.M.G.R Medical University, 
69, Anna Salai, Guindy, 
Chennai 600032 
 
 
For the Award of 
DOCTOR OF PHILOSOPHY 
 
 
 
Submitted By 
Mrs.C.SENTHIL KUMARI,M.Pharm., 
 
 
Under the Guidance of 
Prof. V.VAIDHAYALINGAM 
DIRECTOR 
K.K.COLLEGE OF PHARMACY 
CHENNAI 600128 
 
 
 
ULTRA COLLEGE OF PHARMACY 
4/235, COLLEGE ROAD, THASILDAR NAGAR 
MADURAI 625020 
JUNE 2017 
 CERTIFICATE BY GUIDE 
 
This is to certify that the thesis entitled “EFFECT OF MIRABILIS 
JALAPALINNON REPRODUCTIVE SYSTEM OF MALE ANDFEMALE WISTAR 
RATS-A FOCUS ON ANTIFERTILITY EFFICACY” is a record of research work done 
byC.SENTHIL KUMARI at K.K.College of Pharmacy, Gerugambakkam, Chennai under 
my guidance and supervision during the years 2013 to 2017 and this thesis has not been formed 
the basis for award of any degree, diploma, associate-ship, fellowship or similar title. I also 
certify that the thesis represent work done by the candidate and that this not formed in part or 
fully the basis for the award of any other previous research degree 
 
 
 
Place: Chennai    Prof. V. Vaidhyalingam, M.Pharm., Ph.D., 
Date:      Director & Professor 
      K.K.College of Pharmacy 
      Chennai -600 122 
 
 
CERTIFICATE BY CO-GUIDE 
 
This is to certify that the thesis entitled “EFFECT OF MIRABILIS 
JALAPALINNON REPRODUCTIVE SYSTEM OF MALE ANDFEMALE WISTAR 
RATS-A FOCUS ON ANTIFERTILITY EFFICACY” is a record of research work done by 
C.SENTHIL KUMARI at K.K.College of Pharmacy, Gerugambakkam, Chennai under 
my guidance and supervision during the years 2013 to 2017 and this thesis has not been formed 
the basis for award of any degree, diploma, associate-ship, fellowship or similar title. I also 
certify that the thesis represent work done by the candidate and that this not formed in part or 
fully the basis for the award of any other previous research degree 
 
 
 
Place: Chennai    .A. BabuThandapani, M.Pharm, Ph.D., 
Date:      Vice Chairman,  
      Ultra College of Pharmacy 
      Madurai -625020 
 
  
 
 
 
 
NO OBJECTION CERTIFICATE FROM THE HEAD OF THE INSTITUTION 
 
 
 
Consent is hereby given to Mrs. C. SenthilKumari to carryout Research Work entitled 
“EFFECT OF MIRABILIS JALAPALINNON REPRODUCTIVE SYSTEM OF MALE 
ANDFEMALE WISTAR RATS-A FOCUS ON ANTIFERTILITY EFFICACY” in this 
Institution which is affiliated to The Tamil Nadu Dr. M.G.R. Medical University. 
 
Name of the Institution : Ultra College of Pharmacy 
There is no objection for the above mentioned candidate to do the research work in the selected 
department of this institution 
 
Station : Madurai       Signature  
Date: 29th June 2017 
  
 
 
 
 
 
NO OBJECTION CERTIFICATE FROM THE HEAD OF THE DEPARTMENT 
 
 
Consent is hereby given to Mrs. C. SenthilKumarito carryout Research Work entitled 
“EFFECT OF MIRABILIS JALAPALINNON REPRODUCTIVE SYSTEM OF MALE 
ANDFEMALE WISTAR RATS-A FOCUS ON ANTIFERTILITY EFFICACY” in this 
Institution which is affiliated to The Tamil Nadu Dr. M.G.R. Medical University. 
 
Name of the Institution : Ultra College of Pharmacy 
There is no objection for the above mentioned candidate to do the research work in the selected 
department of this institution 
 
Station : Madurai       Signature  
Date: 29th June 2017 
  
 
 
 
DECLARATION 
 
I hereby declare that the thesis entitled “EFFECT OF MIRABILIS JALAPALINNON 
REPRODUCTIVE SYSTEM OF MALE ANDFEMALE WISTAR RATS-A FOCUS ON 
ANTIFERTILITY EFFICACY” submitted by me for the award of degree of Doctor of 
Philosophy in Pharmacy of The Tamil Nadu Dr. M.G.R Medical University, Chennai is the 
result of my original and independent work done at K.K.College of Pharmacy, 
Gerugambakkam, Chennai 600 122 during the years 2013 to 2017 under the supervision of 
Prof. V.Vaidhyalingam, M.Pharm., Ph.D., Director & Professor, K.K.College of Pharmacy, 
Chennai 600122 and has not been formed the basis for the award of any degree, diploma, 
associate-ship, fellowship or other similar title previously. 
 
 
Place: Chennai      (C.SENTHIL KUMARI) 
Date: 
 
 ACKNOWLEDGEMENT 
I owe a deep sense of gratitude to Almighty whose choicest blessings made me to accomplish 
the work successfully. 
I highly indebted to Mr. K.R. Arumugam, M.Pharm., Chairman, K.K. College of 
Pharmacy, Chennai for timely help, support, care and encouragement. 
I take this opportunity to thank my Guide and Supervisor Prof. Dr.V.Vaidhyalingam, 
M.Pharm, Ph.D., Director, K.K. College of Pharmacy, Chennai, for his guidance, valuable 
suggestions, steadfast support and encouragement for successful completion of my research 
work. 
I sincerely thank Prof.A. BabuThandapani, M.Pharm, Ph.D., Vice Chairman, Ultra 
College of Pharmacy, Madurai, for constant support and co-operation extended during my 
thesis work 
I express my gratitude to Dr. A. Meena, M.Pharm, Ph.D., Principal, K.K. College of 
Pharmacy,, Chennai for her hearty co-operation and valuable guidance throughout the entire 
journey of thesis work. She has always motivate me to bring innovation and ideas in  my 
research work and wish to express my sincere thanks to her. 
I owe my sincere thanks to Dr. Shanthi, M.Pharm, Ph.D., Vice Principal, K.K. College of 
Pharmacy, Chennai for providing valuable support during my research work 
I extend my heartfelt thanks to Dr. C. VijayaM.Pharm, Ph.D., Ultra Trust, Madurai, and 
Dr. K.L. Senthil Kumar M.Pharm, Ph.D., for valuable guidance during my research work. 
 
 I thank my Mother Sethammal who has given me the strength and courage and for all the 
encouragement and my family member Mr. D.Ravishankarand Master R.RahulSailesh for 
their patience and full encouragement and support during the entire period of research work 
 
C.SenthilKumari 
 
 
 
 
 
 
 
 
 
 
 CONTENTS 
CHAPTER 
NO 
TITLE PAGE NO. 
I INTRODUCTION 1 
II AIM AND OBJECTIVE OF THE STUDY 6 
III REVIEW OF LITERATURE 11 
IV MATERIALS AND METHODS 16 
V RESULTS AND ANALYSIS 37 
VI DISCUSSIONS 104 
VIII SUMMARY AND CONCLUSION 108 
VII IMPACT OF THE STUDY 112 
 BIBILIOGRAPHY 113 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
LIST OF TABLES 
TABLE 
NUMBER 
TITLE PAGE 
NUMBER 
5.1 Preliminary Phyto-chemical screening of various extracts of 
leaves of Mirabilis jalapaLinn 
37 
5.2 Body weight (g) of albino rats exposed to ethanolic extract of 
Mirabilis jalapa Linn for 28 days 
39 
5.3 Water (ml/day) intake of albino rats exposed to for 28 days 39 
5.4 Food (g/day) intake of albino rats exposed to ethanolic extract 
of Mirabilis jalapa for 28 days 
40 
5.5 Hematological parameters after 28days treatment with 
Pithapaandumaathirai 
40 
5.6 Effect of treatment with ethanolic extract of mirabilis jalapa  
on biochemical parameters 
41 
5.7 RFT 42 
5.8 Lipid Profile 43 
5.9 Urine Analysis 44 
5.10 Effect of oral administration of ethanolic extract of mirabilis 
jalapa on organ Weight 
45 
5.11 Estrogenic and antiestrogenic activity of the ethanolic extract 
of mirabilis jalapa Linn in rats 
56 
5.12 Histological changes in the uterus and endometrium after 
treatment with the ethanolic extract of mirabilis jalapa in rats 
58 
5.13 Changes in the body weight in the ethanolic extract of 
mirabilis jalapa Linn 
60 
5.14 Effect of ethanolic extract of  mirabilis jalapa  on  reduction  
in pregnancy in rats 
62 
5.15 Effect of ethanolic extract of mirabilis jalapa on blood 
glucose, cholesterol and triglycerides 
64 
5.16 Effect of ethanolic extract of mirabilis jalapa on the estrus 
cycle 
66 
5.17 Effect of ethanolic extract of mirabilis jalapa on ovary and 68 
uterine weight 
5.18 Effect of Ethanolic extract of mirabilis jalapa on biochemical 
change in Ovary and Uterus 
70 
5.19 Effect of ethanolic extract of  mirabilis jalapa  on  reduction  
in pregnancy in rats 
73 
5.20 Effect of ethanolic extract of mirabilis jalapa on blood 
glucose,cholesterol and triglycerides 
75 
5.21 Effect of ethanolic extract of Mirabilis jalapalinn on 
abortifacient activity in female rats 
77 
5.22 Effect of extracts on reproductive outcome 79 
5.23 Hormonal Level in various groups of animals 80 
5.24 Effect of Mirabilis Jalapa on body weight and reproductive 
organ weight of male albino rats 
83 
5.25 Effect of Mirabilis Jalapa on body weight and vital  organ 
weight of male albino rats 
85 
5.26 Effect of  Oral Administrata of Mirabilis jalapa Linn on 
Serum Level of reproductive hormones of male rats (n=6) 
88 
5.27 Effect of Oral administrative of Mirabilis jalapa Linn on 
Semen Characteristics and Fructose Content in Seminal 
Vesicle of Male Rats 
91 
5.28 Effect of Oral Administrative of Mirabilis jalapa Linn extract 
on  mating trial of male rats with normal untreated females 
(mating ration – 1 male:2 females) 
94 
5.29 Effect of Oral administration of Mirabilis jalapa Linn on 
Serum Levels of AST, ALT, Urea, Creatinine of male rats 
97 
5.30 Haematological Analysis of male rats after treatment with 
Ethanolic Extract of Mirabilis jalapa Linn 
100 
5.31 Results of sperm HOS,EY and SCD tests in Ethanolic extract 
of Mirabilis jalapa Linn 
103 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
LIST OF FIGURES 
FIGURE 
NUMBER 
TITLE PAGE 
NUMBER 
1.0 A World Map showing Global Variations in Fertility Rate Per 
Woman 
2 
5.1 Estrogenic and antiestrogenic activity of the ethanolic extract 
of mirabilis jalapa Linn in rats 
57 
5.2 Histological changes in the uterus and endometrium after 
treatment with the ethanolic extract of mirabilis jalapa in rats 
59 
5.3 Changes in the body weight in the ethanolic extract of 
mirabilis jalapa Linn 
61 
5.4 Effect of ethanolic extract of  mirabilis jalapa  on  reduction  
in pregnancy in rats 
63 
5.5 Effect of ethanolic extract of mirabilis jalapa on blood 
glucose,cholesterol and triglycerides 
65 
5.6 Effect of ethanolic extract of mirabilis jalapa on the estrus 
cycle 
67 
5.7 Effect of ethanolic extract of mirabilis jalapa on ovary and 
uterine weight 
69 
5.8 Effect of Ethanolic extract of mirabilis jalapa on biochemical 
change in Ovary 
71 
5.9 Effect of Ethanolic extract of mirabilis jalapa on biochemical 
change in uterus 
72 
5.10 Effect of ethanolic extract of mirabilis jalapa Linn on 
reduction in pregnancy in rats 
74 
5.11 Effect of ethanolic extract of mirabilis jalapa on blood 
glucose,cholesterol and triglycerides 
76 
5.12 Effect of ethanolic extract of Mirabilis jalapalinn on 
abortifacient activity in female rats 
78 
5.13 Effect of mirabilis jalapa on Hormonal Level  of animals 81 
5.14 Effect of mirabilis jalapa on Hormonal Level  of animals 82 
5.15 Effect of Mirabilis Jalapa on body weight and reproductive 
organ weight of male albino rats 
84 
5.16 Effect of Mirabilis Jalapa on body weight and vital organ 
weight of male albino rats 
86 
5.17 Effect of Oral Administrata of Mirabilis jalapa Linn on 
Serum Level of reproductive hormones of male rats 
89 
5.18 Effect of Oral Administrata of Mirabilis jalapa Linn on 
Serum Level of reproductive hormones of male rats 
90 
5.19 Effect of Oral administrative of Mirabilis jalapa Linn on 
Semen Characteristics and Fructose Content in Seminal 
Vesicle of Male Rats 
92 
5.20 Effect of Oral administrative of Mirabilis jalapa Linn on 
Semen Characteristics and Fructose Content in Seminal 
Vesicle of Male Rats 
93 
5.21 Effect of Oral Administrative of Mirabilis jalapa Linn extract 
on  mating trial of male rats with normal untreated females 
(mating ration – 1 male:2 females) 
95 
5.22 Male fertility Index(%) 96 
5.23 Effect of Oral administration of Mirabilis jalapa Linn on 
Serum Levels of AST, ALT, Urea, Creatinine of male rats 
98 
5.24 Effect of Oral administration of Mirabilis jalapa Linn on 
Serum Levels of AST, ALT, Urea, Creatinine of male rats 
99 
5.25 Haematological Analysis of male rats after treatment with 
Ethanolic Extract of Mirabilis jalapa Linn 
101 
5.26 Haematological Analysis of male rats after treatment with 
Ethanolic Extract of Mirabilis jalapa Linn 
102 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 ABBREVIATION 
AFM : Atomic Force Microscopy 
ALT : Alanine amino transferase 
AST  : Aspartate amino transferase 
CIA : Central Intelligence Agency 
DNA : Deoxyribo nucleic acid 
EDAX :Energy Dispersive Spectroscopy 
EDTA :EthyleneDiamine Tetra Acetic Acid 
EEMJ : Ethanolic Extract of Mirabilis jalapa Linn 
FSH :Follicle Stimulating Hormone 
FTIR : Fourier Transform Infrared Spectroscopy 
GCMS: Gas Chromotagraphy – Mass Spectrometry 
GOT : Glutamate Oxalo Acetate Transaminase 
GPT :Glutamate Pyruvate Transaminase 
HB :Haemoglobin 
HOS :Hypo-Osmotic Swelling 
HPLC :High Performance Liquid Chromotagraphy 
LH :Luteinizing Hormone 
LFT : Liver Function Test 
LCMS :Liquid Chromatography Mass Spectrometry 
MJ : Mirabilis jalapaLinn 
MCV :Mean Corpuscular Volume 
OECD :Organization for Economic Co-operation and Development 
PRB :Population Reference Bureau 
RBC : Red Blood Corpuscles  
RFT :Renal Function Test 
SCD :Sickle Cell Disease 
TC :TotalCholestrol 
TEM : Transmission Electron Microscopy 
TLC :Total Leucocyte Count 
TG :Tri Glyceride 
WHO :World Health Organization 
XRD :X-Ray Diffraction 
XTH : XyloGlucan Endo Transglucosylase Hydrolase 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
INTRODUCTION 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
I. INTRODUCTION 
1.1 GLOBAL HUMAN POPULATION (1) 
As per 2016 World Population Data Sheet published by Population Reference 
Bureau(PRB)USA, the world population in the year 2016 is 7.4 Billion and it projects the 
world population would reach 9.9 billion in the year 2050(2). The population would become 10 
Billion in the Year 2053 as per the PRB’s for the Year 2050 projections. It is up 33% increase 
from the Year 2016 of 7.4 Billion Population. Continent wise population increase by the year 
2050 would be Africa will reach 2.5 Billion, Asia will be 5.3 Billion, Europe will be declined 
to 728 million from 740 million, USA will rise to 1.2 Billion and Australia and New Zealand 
combined together will increase from 40 million to 66 million.Many nations with rapid 
population growth have low standards of living, whereas many nations with low rates of 
population growth have high standards of living. 
There are 48 least developed countries as per United Nations Criteria will have population 
double by 2050 to 1.9 Billion. Population in 29 countries will more than double and all of those 
countries are in Africa. Nearly 42 Countries will register population declines, these countries 
are located in Asia, Latin America and Europe. Some countries will post significant declines 
such as Romania which is projected to have a population of 14 million in 2050, down from 20 
million in the Year 2016. 
According to the Data Sheet’s estimates of current population, 25 percent of the world's 
population is less than 15 years old which includes 41 percent is from least developed countries 
and 16 percent in more developed countries.Japan has the oldest population profile, with over a 
quarter of its citizens older than 65. Qatar and the United Arab Emirates are at the other end of 
the spectrum, with each having only 1 percent over 65. 
The top 10 fertility rates in the world are in sub-Saharan African countries, with nearly all 
above six children per woman, and one topping seven. In Europe, the average is 1.6.Thirty-
three countries in Europe and Asia already have more people over age 65 than under 15.Fig 
1.0world map showing global variations in fertility rate per woman published by CIA, USA. 
 
  
Figure 1.0 A World Map showing Global Variations in Fertility Rate Per Woman
Source: Central Intelligence Agency, USA 
 
1.2 FERTILITY CONTROL FOR POPULATION GRO
The most preferred method for fertility control is cont
for preventing the pregnancies temporarily or permanently. Ideally the method shall 
be safe, effective, acceptable, inexpensive, user controlled with minimal side effects 
and protective against infection. There are many contra
used to control population growth and most widely used method is oral 
contraceptive which has serious side effects and the most common is 
uterine bleeding pattern at menses or between menses, such as decreased bleedi
menses, breakthrough bleeding or spotting between periods, prolonged bleeding at 
menses, complete stopping of menstrual bleeding that occurs over several months in 
a row, or stopping of menstrual bleeding that only occurs sometimes
In order to overcome these side effects, there is an urgency to meet the requirement 
of safe and active natural contraceptive agents with minimal side effects. 
– World Fact Book 2016 Data
WTH (4) 
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 1.3 TRADITIONAL MEDICINE(5) 
Traditional medicines includeAyurveda,Siddha medicine,Unani,ancient Iranian 
medicine,Iranian (Persian),Islamic medicine,traditional Chinese medicine,traditional Korean 
medicine,acupuncture,Muti,Ifá, andtraditional African medicine. Core disciplines which study 
traditional medicine includeherbalism,ethno-medicine,ethnobotany, andmedical anthropology. 
The WHO notes, however, that "inappropriate use of traditional medicines or practices can 
have negative or dangerous effects" and that "further research is needed to ascertain the 
efficacy and safety" of several of the practices and medicinal plants used by traditional 
medicine systems. The line between alternative medicine and quackery is a contentious subject. 
Traditional medicine may include formalized aspects of folk medicine, that is to say 
longstanding remedies passed on and practised by lay people. Folk medicine consists of 
the healing practices and ideas of body physiology and health preservation known to some in a 
culture, transmitted informally as general knowledge, and practiced or applied by anyone in the 
culture having prior experience(7). Folk medicine may also be referred to as traditional 
medicine, alternative medicine, indigenous medicine, or natural medicine. These terms are 
often considered interchangeable, even though some authors may prefer one or the other 
because of certain overtones they may wish to highlight. In fact, out of these terms perhaps 
only indigenous medicine and traditional medicine have the same meaning as folk medicine, 
while the others should be understood rather in a modern or modernized context(8). 
1.4 HUMAN FERTILITY CONTROL 
Human fertility control is one of the major approaches which seem effective in controlling 
population. Many potential methods have been adopted to induce infertility including hormonal 
and chemical methods. Traditional use of medicinal plants and their extracts have become 
widely known among society for various diseases including fertility related problems. 
Considering women healthcare, it has become important to use herbal anti-fertility agents 
which can interfere with the natural procedure of reproduction in women. Modern research 
includes the use of various plant extracts having anti-fertility action in various ways. Numerous 
herbs have been tested for their contraceptive activity on different animal models. These herbal 
contraceptives are found tobe eco-friendly, can be easily available and affordable even in rural 
areas. They are more effective but less potential than synthetic drugs. Antifertility drugs are 
closed to control fertility and also used as oral contraceptive. These herbs act on females to 
prevent fertilization, prevent ovulation, implantation, destroys the zygots, abortion. In males, 
the drugs accts to prevent spermatogenesis, inhibit male hormone, reduces the sperm count, 
affects the gonadotropin of the organ. Some herbal plants used as anti-fertility in males 
eg.Abrus precatorious reduces sperm motility and density, Abrus20 Concinna reduces 
spermicidal and sperm coagulating activities, Cananga Odorata reduces depididymal sperm 
motility, sperm count in and and abnormality in sperm mohphology, Achilleamille Folium 
produces spermicidal action.Very few studies havebeen carried out to confirm the safety and 
efficacy of medicinal plants used as anti-fertility agents. 
Some herbal plants used as antifertility in females  for example Croton Roxburghii have anti 
estrogenic activity, Curcuma Aromatic have anti estrogenic activity, Trichosanthes 
Cucumberina produces Estrious Cycle showing a significant increase in Estrous and Metestrus 
Phase, Cassia Fistula have anti-implantation activity, Sesbania Sesban inhibit the ovarian 
function, Trigonella Foenum Greacum have anti-estrogenic and anti-fertility activity, Ballota 
undulate have negative effects on fertility and pregnancy. 
1.5 MECHANISM OF ACTION OF ANTIFERTILITY PLANTS 
The herbal plants which has anti-fertility activity act as preventing ovulation, implantation, 
abortification action, altering the hormones, uterine stimulant, uterine relaxant, estrogenic and 
anti estrogenic, ovulatory and anti-ovulatory, progesterogenic, androgenic and andti-
androgenic, anti-spermatogenic and spermicidal activity.The  hormones  such asfollicle 
stimulating hormone (FSH) and Luteinizing hormone (LH) are controlled by hypothalamus for 
the action of Uterus. 
Plants which have anti-fertility has the site of action on hypothalamus, the anterior pituitary, 
the ovary, the oviduct, the uterus and the vagina. 
Alteration in the hormonal function of the hypothalamus or pituitary by the anti-fertility agents 
which affects the neuronal pathway to the hypothalamus. 
 
 
 
 
 1.6 DESCRIPTION AND MEDICINAL USE OF MIRABILIS JALAPA LINN 
Mirabilis jalapa Linn belongs to the family Nyctaginaceae, Species:M jalapa Linn, 
Kingdom:Plantae, Sub Kingdom:Tracheobionta Order:Caryophyllales, Genus :Mirabilis,  
 
Vernacular Names 
In Tamil Nadu it is known as andhi mandhaaraiand in Andhra Pradesh it is called as 
chandrakantha indraganti, and in Karnataka it is called assanje mallige, in Malayalam it is 
called as naalumani poovu, in Maharastra it is called as gulabakshi, in Odhisa it is called as 
rangani and in Punjab it is called as sham di sohnap, which means "evening beauty 
 
Synonyms areMirabilis lindheimeri, M. dichotoma, M. Odorata and Common Names 
areClavillia, four-o’clocks, jalap, maravilla, bonina 
 
Description 
 
Mirabilis jalapaLinn is commonly called Four O Clock or Marble of Peru. Branching Stems 
grows to an extent of 36” with tall and erect in size and it is a perennial herb which is bushy 
and tender. Generally grows in various colours such as pink, rose, red, magenta, yellow and 
white and different colour appears in same plant. The flower blossom around 4 O’ Clock and 
continue to blossom till morning. Size of the leaves are in Ovate and Dark Green colour and 
generally appears as heart shape at the base. 
 
Mirabilis jalapais used in inflammation, in skin disease,as anaesthetic, as anthelmintic, in 
bronchitis, in kidney problems, in blood & vaginal disease. In the ethanobotanical claim, 
Mirabilis jalapaLinn leaves and flowers are used to control child birth or for fertility regulation 
in India. In South India, tribal women use this leaves for contraception. Leaves are crushed and 
mixed with jaggery and made into pills. Each pill is taken earlyin the morning for nine days 
after menstruation .Literature reviews indicated that anti-fertility activity of leaves of mirabilis 
jalapaLinn. has not been scientifically evaluated so for. Inview of this, the present study was 
aimed at evaluating theanti-fertility activity of leaves of Mirabilis jalapaLinn in female and 
male albinorats. 
 
II. AIM AND OBJECTIVES OF THE STUDY 
2.1 AIM OF THE STUDY 
Human Population has been on increasing trend for the last 60 years due to the continuous 
innovation in medical field to meet the challenges occurs at various period as well as the 
increased agricultural productivity in order to meet the food requirements of the world 
population. The fact that indicates the increasing population trend in the 21st Century is due to 
increase in birth rate and declining trend in mortality rate globally. Overall effect of increasing 
population trend results in resource depletion such as safe drinking water, non-availability of 
food for burgeoning population, starvation, malnutrition, over exploitation of natural resources. 
To mitigate this problem exponential population growth shall be controlled and monitored. 
Several preventive and corrective methods for modern medicine are available, however, it is 
not safe due to serious side effects such as obesity, gastric problems, cholelithiasis, carcinoma 
of breast and cervix, venous emobolism.  
In order to overcome these side effects, there is an urgency to meet the requirement of safe and 
active natural contraceptive agents with minimal side effects. In ancient and modern 
pharmacology period, several number of medicinal plants having anti-fertility efficacy e.g..for 
male Concinna reduces spermicidal and sperm coagulating activities, Cananga Odorata reduces 
depididymal sperm motility, sperm count in and and abnormality in sperm mohphology, 
Achilleamille Folium produces spermicidal action and for Female eg., Croton Roxburghii have 
anti estrogenic activity, Curcuma Aromatic have anti estrogenic activity, Trichosanthes 
Cucumberina produces Estrious Cycle showing a significant increase in Estrous These plants 
have valuable sources of herbal contraceptives in male and females. Different ways are 
available for herbs act on male and females to impair fertility. 
Antifertility drugs are closed to control fertility and also used as oral contraceptive. These 
herbs act on females to prevent fertilization, prevent ovulation, implantation, destroys the 
zygots, abortion. In males, the drugs accts to prevent spermatogenesis, inhibit male hormone, 
reduces the sperm count, affects the gonadotropin of the organ. 
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2.2 OBJECTIVE OF THE STUDY 
The present study is designed to ascertain the effect of the Ethanolic extract of mirabilis 
jalapaLinn on Phyto-chemical and pharmacological studies inalbino wistarrats. 
 
2.2.1 Collection and Authentication and Extraction 
• Collection of the leaves of mirabilis jalapa Linn. 
• Authentication of the plant 
• Extraction by using different solvents(Ethanol, Acetone, Petroleum ether, Ethyl 
Acetate and Aqueous) 
 
2.2.2. Phyto- Chemical Studies 
• To study the preliminary Phyto-chemical analysis of different solvent extract of 
mirabilis jalapa linn.. 
 
2.2.3. Toxicity Studies 
• To study the acute toxicity studies (according to OECD guidelines 423) 
 
• To study the  sub-acute toxicity studies (according to OECD guidelines 407) 
of the Ethanolicexract of mirabilis jalapa linn. 
 
2.2.4. Pharmacological Studies 
Invivo studies: 
 
 To study the antifertility effect of ethanolic  extract of mirabilis jalapa Linn on 
female albino wistar rats 
 To evaluate estrogenic and antiestrogenic activity on female wistar rats. 
 To evaluate the antiovulatory effect on female albino wistar rats. 
 To evaluate the antiimplantation effect on female albino wistarrats. 
 To evaluate the Reversible antifertility effect on female albino wistar rats. 
 Abortifacient activity. 
  
 
 To Study the antifertility effect of ethanolic  extract of mirabilis jalapa linn  on 
male albino wistar rats 
 
 To evaluate the Antispermatogenic activity on male albino wistar rats. 
 To evaluate the fertility  test  on male albino wistarrats. 
 To evaluate the Reversible  antifertility effect on male albino wistar rats 
 
 Invitro Studies: 
 
 Spermicidal test  for male albino wistar rats 
 Uterine contractility for female albino wistar rats 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
PLAN OF THE WORK 
 
 
The present study is designed to ascertain the effect of the Ethanolic extract of mirabilis 
jalapaLinn on Phyto-chemical and pharmacological studies inalbino wistarrats. 
 
 
PHARMACOGNOSTICAL WORK: 
1. Collection of the leaves of Mirabilis jalapa Linn. 
 
2. Authentication of the plant 
 
3. Extraction of the leaves of mirabilis jalapa. 
 
 
PHYTO- CHEMICAL STUDIES 
 
• To study the preliminary Phytochemical analysis of the were carried out in different  
solvents of the extract of mirabilis jalapa Linn.. 
 
 
TOXICITY STUDIES 
• To study the acute toxicity studies (according to OECD guidelines 423) 
 
• To study the  sub-acute toxicity studies (according to OECD guidelines 407) 
of the Ethanolicexract of mirabilis jalapa Linn. 
 
PHARMACOLOGICAL STUDIES 
 
Invivo studies: 
 To study the anti-fertility effect of ethanolic extract of mirabilis jalapa Linn on female 
albino wistar rats.. 
• To evaluate estrogenic and antiestrogenic activity on female wistar rats. 
• To evaluate the antiovulatory effect on female albino wistar rats.(7) 
• To evaluate the antiimplantation effect on female albino wistarrats. 
• To evaluate the Reversible antifertility effect on female albino wistar rats. 
• Abortifacient activity. 
 
 To study the anti-fertility effect of ethanolic extract of Mirabilis jalapa Linnonmale 
albino wistar rats. 
• To evaluate the Antispermatogenic activity on male albino wistar rats. 
• To evaluate the fertility test on male albino wistarrats. 
• To evaluate the Reversible  anti-fertility effect on male albino wistar rats 
 
INVITRO STUDIES:. 
 
 Spermicidal test  for male albino wistar rats 
 Uterine contractility for female albino wistar rats 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
REVIEW OF LITERATURE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
III. REVIEW OF LITERATURE 
3.1 LITERATURE SURVEY OFMirabilis jalapaLINN 
The review of literature includes folklore claims,pharmacognosy, pharmacological 
activities of Mirabilis jalapaLinn 
 
3.1.1. Folklore claims 
Ramesh B.,Nidavaniet .al(2014); have reported that an ethano-pharmacological review 
of Four ‘O’Clock flower plant, The components isolated are 
glycosides,alkaloids,carbohydrates,flavonoids,phytosterols(beta-sitosterol and 
stigmasterol),ursolic acid,oleanolic acid,brassicasterol,trigonelline. 
In the study the detailed information in the review of phyto chemical and biological 
properties of the plant for its use of the plant in different diseases have been studied(23). 
Sumithra P, Varalakshmi S, Devasena K24.was attempted to reveal the qualitative 
phyto-chemical analysis of dried flower powder extracted in various solvents like 
aqueous, ethanol, methanol, chloroform and petroleum ether and their antibacterial 
activity against the gastrointestinal infections causing pathogens like Escherichia coli, 
Staphylococcus aureus, Streptococcus pneumoniae, Pseudomonas aeroginosa, 
Klebsiella pneumoniae, Bacillus cereus, Lactobacillus acidophilus, Enterococcus 
faecalis, Salmonella typhi and Shigella dysenteriae. TLC was carried out in all the 
extractions and HPLC and FT-IR were used as confirmatory test to study the nature of 
secondary metabolites. The antibacterial activity of the extracts of Mirabilis jalapa was 
examined by Disc diffusion method. Aqueous, chloroform and petroleum ether extracts 
displayed the minimal inhibition while all the ethanolic and methanolic extracts showed 
good antibacterial activity against the selected pathogens. The bacterial growth 
inhibition was calculated with reference to the standard.(24)
 
 
Ramesh B,Nidavani,Mahalakshmi AM,Mohamed Hajji,Raoudha Jarraya,Imen 
Lassoued,Ons  Masmoudi reported that total phenolic and flavonoid contents varied 
from 21.45 to 364.6 mg gallic acid equivalent (GAE)/g dried extract and 5.2 to 71.6mg 
quercetin/g dried extract, respectively. Water extract of MJT was the most potent 
antioxidant in all assays used, followed by methanol extract. The five solvent extracts 
were screened for antibacterial and antifungal activities. Water extract was the most 
effective with minimum inhibitory concentration <200µg/ml againstStaphylococcus 
aureus,Micrococcus luteus,Pseudomonas aeruginosa, Klebsiella pneumoniae,Bacillus 
cereusandEnterococcus faecalis. Only water extract showed antifungal activity 
againstAspergillus niger,Fusarium solani,Fusarium oxysporium andFusarium 
granularium. GC/MS analysis of MJT dichloromethane and methanol extracts showed 
that oleic acid and β-sitosterol were, respectively, the major compounds. LC/MS 
analysis of the aqueous extract showed a high content of flavanol and flavonol 
compounds. Phenolic acids such as ferulic and caffeic acid were also detected(24). 
Walker et.al(2013);reported that the effect of Eta administered orally (10mg/kg, p.o.) 
in mice was verified on the painful hypersensitivity (mechanical allodynia) in models of 
chronic inflammation (subcutaneous injection of complete Freund's Adjuvant-CFA in 
the plantar surface of the right hind paw), postoperative (paw surgical incision) and 
neuropathic (partial sciatic nerve ligation) pain.Eta produced marked reduction in the 
allodynia caused by CFA, surgical incision and partial sciatic nerve ligation. However, 
Eta did not alter the paw edema or the increase of IL-1β levels produced by CFA. The 
antinociceptive effect of Eta was reversed by the pre-treatment of animals with the 
antagonists of muscarinic (atropine, 5mg/kg, s.c) or nicotinic (mecamylamine, 
0.001mg/kg, s.c.) receptors(25). 
Zhou JY et.al(2012);reported that after induction of diabetes with streptozotocin, both 
normal and diabetic mice were singly or repeatedly for 28 days administrated with 
EEM at doses of 2, 4, 8 g/kg, respectively.Single administration with EEM had no 
hypoglycemic and hypolipidemic effects on normal and diabetic mice. These results 
suggest that EEM possesses both potential insulin sensitivity, hypoglycemic, and 
hypolipidemic effects on diabetes(26). 
 
Singh M et.al,reported that the anti-inflammatory activity was evaluated using 
carrageenan and formalin-induced paw edema models in Wistar albino rats. The anti-
inflammatory activity was found to be dose dependent in carrageenan-induced paw 
edema model The maximum percentage inhibition in paw edema was 32.9% and 43.0% 
on 4 (th) day at the doses of 200 and 400 mg/kg, respectively(27). 
 
Nath et.al ; Anti-inflammatory activity of mirabilis jalapa linn. Leaves. 
Reported that the experimental results have established a pharmacological evidence for 
the folklore claim of the drug to be used as an anti inflammatory agent(28). 
 
Aoki k et al: reported the antispasmodic activity ofMirabilis jalapa Linn flowers.It 
exhibited gut smooth muscle contractilitywhereas it stimulates the contraction of rabbit 
aortic muscle in a concentration-dependent manner(29). 
 
Gogoi J,Nakhuruet al., isolated and characterize bioactive components 
fromMirabilisjalapaLinn.radix ( zǐ mò lì gēn). Thin-layer chromatography was used 
for the separation of spots from fractions of the crude extract. Separated spots were 
collected for identification of their activities. Free-radical scavenging activity was 
evaluated by spraying thin-layer chromatography plates (spotted with fractions) with 
0.2% of 2,2-diphenyl-1-picrylhydrazyl solution. Activity against human pathogens such 
as Staphylococcus aureus and Candida albicans were determined using the agar 
diffusion method. Potential spots were subjected to infrared (IR) analysis and gas 
chromatography for characterization. Two spots (5F1 and 1F3) showed free-radical 
scavenging activity. The 1F3 spot was active against both S. aureus and C. albicans, 
whereas the 5F1 spot was active against S. aureus only. IR spectral analysis indicated 
that 5F1 spot to be a triterpenoid. Using IR spectral analysis and an IR library search, 
the 1F3 spot was identified to be a flavone, which may have a hydroxyl group in ring 
"A" of the flavone nucleus. Our results indicated that the 1F3 and 5F1 spots are 
potential free-radical scavengers. Both 1F3 and 5F1 exhibited antimicrobial activity. IR 
spectral analysis coupled with an IR library search indicated 1F3 and 5F1 to be a 
flavone and a triterpenoid, respectively(30). 
 
Shahri W.et al reported the   isolation, identification and characterization of different 
genes from various flowers (mainly from petals) associated with senescence havebeen 
discussed. The isolated genes were divided into different groups. A large proportion of 
genes have been found to be upregulated during flower senescence while some genes 
were also found to be downregulated indicating that there exists a complex interplay 
between the expression patterns of various genes. The genes involved in petal 
expansion are found to be upregulated during normal flower development from anthesis 
to open flower stage, but XTH (Xyloglucan endotransglucosylase hydrolase) is found to 
be involved in petal expansion as well as abscission. Cysteine proteases or the genes 
encoding cysteine proteases (assigned a central role in protein degradation) have been 
identified from various flower systems, but no cysteine protease has been identified 
from senescing Mirabilis jalapa flowers. In addition to proteases, the genes encoding 
ubiquitin (exhibiting proteasomal degradation by 26S proteasomes) have also been 
identified suggesting the two alternate pathways for protein degradation. Genes 
encoding specific nucleases have also been identified, but they displayed an early 
increase in transcript abundance before the senescence symptoms become evident and 
characterize the involvement of PCD during flower senescence. A range of 
transcription factors are described and their possible role in flower senescence has been 
discussed. A detailed description of genes involved in ethylene synthesis and the 
components involved in ethylene signaling have been presented. 
 
Walker et al;reported that Eta produced marked reduction in the allodynia caused by 
CFA, surgical incision and partial sciatic nerve ligation. However, Eta did not alter the 
paw edema or the increase of IL-1β levels produced by CFA. The antinociceptive effect 
of Eta was reversed by the pre-treatment of animals with the antagonists of muscarinic 
(atropine, 5mg/kg, s.c) or nicotinic (mecamylamine, 0.001mg/kg, s.c.) receptors. Eta 
did not alter in vitro acetylcholinesterase activity in blood or spinal cord samples, but it 
reversed the increase in the acetylcholinesterase activity observed in the spinal cord 
samples from mice injected with CFA. Moreover, Eta did not alter the indicators of 
liver or kidney lesion. 
 
 
Zhou J et alReported that Oxidative stress in diabetes coexists with a reduction in the 
antioxidant status, which can further increase the deleterious effects of free radicals. 
Trigonelline is the major component ofMirabilisjalapa Linn., which has been used to 
treat diabetes in China. The present study was designed to evaluate the beneficial 
effects of trigonelline against hyperglycemia, hyperlipidemia, β cell damage and 
antioxidant of pancreas in diabetic rats. Diabetic rats were induced by intraperitoneal 
injection 35 mg/kg streptozotocin and a high-carbohydrate/high-fat diet. Rats were 
divided into four groups: normal control, diabetic control, trigonelline-treated diabetic, 
and glibenclamide-treated diabetic. After 4-week treatment, blood glucose, serum 
insulin, total cholesterol (TC), and triglyceride (TG) levels, insulin content in pancreas, 
and oxidative stress parameters in pancreatic homogenate were assayed. Pancreas was 
examined by hematoxylin/eosin staining. Trigonelline significantly decreased blood 
glucose, TC, and TG levels of diabetic rats. Pancreas-to-body weight ratio, insulin 
level, insulin sensitivity index, insulin content in pancreas, malonaldehyde and nitric 
oxide contents, and superoxide dismutase, catalase, glutathione and inducible nitric 
oxide synthase activities were altered in diabetic rats, and were near control levels 
treated with trigonelline. These findings suggest that trigonelline has beneficial effect 
for diabetes through decreasing blood glucose and lipid levels, increasing insulin 
sensitivity index and insulin content, up-regulating antioxidant enzyme activity and 
decreasing lipid peroxidation. 
 
lai.et.al reported that Eleven compounds were isolated and identified as astragaloside II 
(1), astragaloside II (2), astragaloside IV (3), astragaloside VI (4), flazin (5), 4'-
hydroxy-2, 3-dihydroflavone 7-beta-D-glucopyranoside (6), gingerglycolipid A (7), 3, 
4-dihydroxybenzaldehyd (8), p-hydroxybenzaldehyde (9), beta-sitosterol (10) and 
daucosterol (11). 
 
Aoki.ket.al studied the extract ofMirabilisjalapaLinn(1-1000 mug/mL) exhibits an 
inhibitory effect (IC(50)=18+/-0.7 micorg/mL) on gut smooth muscle contractility 
whereas it stimulates the contraction of rabbit aortic muscle (EC(50)=11.60+/-0.26 
micorg/mL) in a concentration-dependent manner . 
 
  
 
 
 
 
 
 
 
 
 
MATERIALS AND 
METHODS 
 
 
 
 
 
 
 
 
 
 
 
 
IV.MATERIALS AND METHODS 
PLANT PROFILE 
 
BOTANICAL NAME  :Mirabilis jalapa Linn 
 
Classification  
 
Family    :Nyctagimaceae 
Species   :M jalapa Linn 
Kingdom   :Plantae 
Sub Kingdom   :Tracheobionta 
Order    :Caryophyllales 
Genus    :Mirabilis 
 
Vernacular Names 
Tamil Nadu  andhi mandhaarai 
Andhra Pradesh chandrakantha indraganti,  
Karnataka  sanje mallige 
Malayalam  naalumani poovu 
Maharastra  gulabakshi 
Odhisa    rangani in,  
Punjab,  sham di sohnap, which means "evening beauty  
Synonyms 
Mirabilis lindheimeri, M. dichotoma, M. odorata 
 
Common Names 
Clavillia, four-o’clocks, jalap, maravilla, bonina 
 
 
 
 
 
 
 Image 4.1: Plant of Mirabilis jalapa Linn 
 
 
Image 4.2 -Leaves and Flowers of Mirabilis jalapa Linn 
 
 Mirabilis jalapa, commonly called four-o-clock or marvel of Peru, is native to Peru. It is a 
bushy tender perennial that typically grows to 24-36” (less frequently to 48”) tall on erect, 
branching stems. It is an old garden favorite that features fragrant, funnel-shaped, tubular 
flowers (2” long) with five flaring petal-like lobes. Flowers blooms from early/mid-summer to 
fall. Flowers come in pink, rose, red, magenta, yellow and white, sometimes with interesting 
mottling and striping. Different colored flowers often appear on the same plant. Flowers open 
in the late afternoon (around four o’clock) and stay open only until the following morning. 
Flowers are attractive to hummingbirds. Ovate dark green leaves (to 4” long) are heart-shaped 
at the base. All parts of this plant are poisonous if ingested. 
 
Description 
It is commonly called Four O Clock or Marble of Peru. Branching Stems grows to an extent of 
36” with tall and erect in size and it is a perennial herb which is bushy and tender. Generally 
grows in various colours such as pink, rose, red, magenta, yellow and white and different 
colour appears in same plant. The flower blossom around 4 O’ Clock and continue to blossom 
till morning.Size of the leaves are in Ovate and Dark Green colour and generally appears as 
heart shape at the base. 
 
Main Actions: 
Antiviral, Antibacterial, Anticandidal, Antifungal, Antispasmodic 
 
Main Uses: 
• As a broad-spectrum antimicrobial for bacterial, fungal, and viral infections  
• For Candida and yeast infections  
• As a bowel cleanser and laxative  
• For skin problems (eczema, dermatitis, acne, rashes, liver spots, skin fungi, ringworm)  
• For vaginal discharge, infections, and sexually transmitted diseases  
 
 
 
 
 
PLANT COLLECTION AND AUTHENTIFICATION OF PLANT MATERIAL 
The leaves of the  plant of mirabilis jalapa  was collected from in and around Kanyakumari 
district . The plant was identified and authenticated by Dr.Jeyaraman,  AssistantProfessor of 
Botany ,Chennai. 
EXTRACTION PROCESS: 
Theleaves were shade dried at room temperature. The dried leaves was subjected to size 
reduction to a coarse powder by using dry grinder and pass through sieve. The powder was 
packed in soxlet apparatus and extracted successively with Ethanol(60-80oC). The extract was 
dried at 45oC in hot air oven till solid to semi-solid mass is obtained and are stored in air tight 
container in a refrigerator below 10oC 
PRELIMINARY PHYTO-CHEMICAL SCREENING: 
The different Extractsof mirabilis jalapa was subjected to preliminary phyto chemical 
analysis for the presence or absence of active phyto-chemical constituents by the following 
methods. 
 
1. Test foralkaloids  
Treated with dilute Hydrochloric acid and filtered. The filtrate was treated with various 
alkaloidal agents. 
a) Mayer’s Test : 
To 3ml of filtrate, a few drops of Mayer’s reagent was added and the precipitate was 
observed White color precipitate indicates the presence of alkaloids. 
b) Dragendroff’s Test: 
When little amount of the sample was treated with the Dragendroff’s reagent, the 
appearance of reddish brown precipitate indicates the presence of alkaloid. 
c)Hager’s Test : 
Treated with the Hager’s reagent, the appearance of yellow colour precipitate 
indicates the presence of alkaloid. 
d) Wagner’s Test: 
Treated with the Wagner’s reagent, the appearance of brown colour precipitate 
indicates the presence of alkaloid. 
 
2. Test for Carbohydrates : 
 
a) Fehling’s Test: 
The extracts were treated with Fehling’s solution A and B and heated. 
Appearance of reddish brown colour precipitate indicates the presence of 
reducing sugars. 
 
b) Benedict’s Test 
Equal quantity of Benedict’s reagent and extract were mixed in a tube and heated 
for 5 minutes with boiling water. Green or Red colour changes indicates the 
presence of reducing sugar from Blue color 
 
c) Barfoed’s Test : 
The extracts were treated with Barfoed’s reagent and heated. Appearance of 
reddish orange colour precipitate indicates the presence of non–reducing sugars. 
 
d) Molisch’s test: 
Molisch reagent: 10 gm of alpha naphthol was dissolved in 100 ml of 95% 
methanol to prepare Molisch reagent. To the extract, two drops of Molisch reagent 
and few drops of concentrated H2SO4 is added, formation of purple-violet ring 
indicates the presence of carbohydrates. 
 
3.Test for Proteins: 
a) Biuret Test 
To 3 ml of the extract, 4% of Sodium Hydroxide and few drops of 1% copper 
sulphate solutions were added and mixed. Blue colour turns violet in the presence fo 
protein. 
 
b) Millon’sTest : 
3 ml of extract mixed with 5 ml of Millon reagent.Purple red colour precipitate 
indicate the presence of Protein. 
 
 
 
4.Test for Steroids : 
a) LibermannBurchard Test : 
When the extracts were treated with concentrated sulphuric acid, few drops of 
glacial acetic acid, followed by the addition of acetic anhydride, appearance of 
green colour indicates the presence of steroids. 
 
5.Test for Sterols : 
When the extracts were treated with 5% potassium hydroxide solution, 
appearance of pink colour indicates the presence of sterols. 
 
6. Test for Phenols : 
• When the extracts were treated with neutral ferric chloride solution, the 
appearance of violet colour indicates the presence of phenols. 
• When the extracts were treated with 10% sodium chloride solution, the 
appearance of cream colour indicates the presence of phenols. 
 
7.Test for Tannins : 
a) When the extracts were treated with 10% lead acetate solution, appearance of 
white precipitate indicates the presence of tannins. 
b) When the extracts were treated with aqueous bromine solution, appearance of 
white precipitate indicates the presence of tannins. 
 
8.Test for Flavanoids: 
a) 5ml of the extract solution was hydrolyzed with 10 % v/v sulphuric acid and 
cooled. Then, it was extracted with diethylether and divided into three portions 
in three separate test tubes. 1 ml of diluted sodium carbonate, 1 ml of 0.1N 
sodium hydroxide, and 1ml of strong ammonia solution were added to the first, 
second and third test tubes respectively. 
 
b) Shinoda's test: The extract dissolved in 5ml of 95% ethanol treated with conc. 
HCl and magnesium turning was observed and note down. Appearance of 
magenta color shows the presence of flavonoids. 
 
 
9. Test for Gums and Mucilage: 
The extracts were treated with 25 ml of absolute alcohol, then solution was filtered. 
The filtrate was examined for its swelling properties. 
 
10. Test for Glycosides: 
1 ml extract a mixture anthrone and concentrated HCl acid was added and warmed on 
water bath red coloration was formed indicates the presence of Glycosides. 
 
11.Test for Saponins: 
Foam test: 
1ml of the extracts are diluted to 20 ml with distilled water and shaken well in a test 
tube. The formation of foam in the upper part of the test tube indicates the presence of 
saponins. 
 
12.Test for Terpenes: 
When the extracts were treated with Tin and thionyl Chloride, appearance of pink 
colour indicates the presence of terpenes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 PRECLINICAL TOXICITY STUDIES  
ACUTE ORAL TOXICITY – ACUTE TOXIC CLASS METHOD-423(31) 
Experimental Animals: 
Albino rats (wistar rats) of either sex,weighing (150-250 g) were placed in a polypropylene 
cages in a controlled room temperature 240C±10C and relative humidity of 60-70 % in animal 
house.The animals were maintained in standard pellet diet and water ad libitum.They were 
acclimatized to laboratory condition for seven days before commencement of the experiment. 
Animal experimentation protocols are approved by Institutional Animal Ethical 
Committee.(Ref:KKCP/2015/038). 
Drug and Preparation of Stock Solution 
The ethanolic extract  of mirabilis jalapa was prepared in 1% carboxymethycellulose (CMC) 
solution in distilled water prior to oral administration to animals.It was used within seven days 
and stored at 8oC while for further use,freshly prepared solution was used.The vehicle alone 
served as control. 
Number of animals and dose levels: 
Three animals are used for each step. The dose level used as the starting dose was selected 
from one of four fixed levels, 5, 50, 300 and 2000 mg/kg body weight. The starting dose level 
was most likely to produce mortality in some of the dosed animals. The available information 
suggests that mortality is likely at the highest starting dose level 2000 mg/kg body weight, so 
the trial or limit test was conducted.. 
 
OBSERVATIONS: 
Animals were observed individually for the signs of toxicity All observations are 
systematically recorded with individual records being maintained for each animal. Attention 
was directed to observations of tremors, convulsions, salivation, diarrhea, lethargy, sleep and 
coma. The principles and criteria summarized in the Humane Endpoints Guidance Document 
taken into consideration. Animals found in a moribund condition and animals showing severe 
pain or enduring signs of severe distress was humanely killed. When animals are killed for 
humane reasons or found dead, the time of death should was recorded. 
 REPEATED DOSE 28-DAY SUB-ACUTE ORAL TOXICITY STUDY OF ETHANOLIC 
EXTRACT OF Mirabilis jalapa Linn  ON RATS (OECD – 407 GUIDELINES)(32) 
Test Substance: mirabilis jalapaLinn 
Animals: Male and Female Wistar albino Rats  
Age: More than8 weeks 
Acclimatization: Seven days prior to dosing. 
Veterinary examination: Prior to and at the end of the acclimatization period. 
Identification of animals: By cage number, animal number and individual marking on fur. 
Diet: Pelleted feed supplied by Sai meera foods Pvt Ltd, Bangalore 
Water: Aqua guard portable water in polypropylene bottles ad libitum. 
Housing & Environment: The animals were housed in Polypropylene cages provided with 
bedding of husk. 
Housing temperature: Between 20 & 24°C,  
Relative humidity:  Between 30% and 70%, 
Air changes:  10 to 15 per hour and  
Dark and light cycle: Each of 12 hours. 
 
 
 
Justification for Dose Selection: 
 The results of acute toxicity studies in wistar rats indicated that Mirabilis jalapawas 
non toxic and no behavioural changes was observed up to the dose level of 2000 mg/kg body 
weight. In the literature, therapeutic dosage forMirabilis jalapa in human is mentioned as 1000 
mg. On the basis of body surface area ratio between rat and human, the doses selected for the 
study were 200 mg/kg (5x) and 400 mg/kg (10x) body weight. The oral route was selected for 
use because oral route is considered to be a proposed therapeutic route. 
Preparation and administration of dose:  
Ethanolic extract of Mirabilis jalapaat two doses respectively was suspended in 2 ml of 2% 
CMC in distilled water. It was administered to animals at the dose levels of  200 and 400 
mg/kg. The test substance suspensions were freshly prepared every day for 28 days. The 
control animals were administered vehicle only. Administration was by oral (gavage), once 
daily for 28 consecutive days. 
METHODOLOGY(33) 
Randomization, Numbering and Grouping of Animals: 
 Ten rats (Five Male and Five Female) were in each group randomly divided into four 
groups for dosing up to 28 days. Animals were allowed acclimatization period of 7 days to 
laboratory conditions prior to the initiation of treatment. Each animal was fur marked with 
picric acid. The females were nulliporous and non-pregnant. 
OBSERVATIONS(34): 
Experimental animals were kept under observation throughout the course of study for 
the following: 
(i) Body Weight: Weight of each rat was recorded on day 0, at weekly intervals throughout the 
course of study and at termination to calculate relative organ weights. From the data, group 
mean body weights and percent body weight gain were calculated.  
(ii) Food and water Consumption: The quantity of food consumed by groups consisting of six 
animals of for different doses was recorded at weekly interval. Food consumed per animal was 
calculated for control and the treated dose groups.  
(iii) Clinical signs: All animals were observed daily for clinical signs. The time of onset, 
intensity and duration of these symptoms, if any, were recorded. 
(iv) Mortality: All animals were observed twice daily for mortality during entire course of 
study. 
(v) Ophthalmoscopy: The eyes of experimental animals in control as well as treated groups 
given different dose levels were examined prior to the initiation of the dosing and in 4th and the 
6th week of the study. Eye examination was carried out using a hand slit lamp after induction of 
mydriasis with Atropine sulphate solution. 
(vi) Functional Observations: At the end of the 4th week exposure, ‘sensory reactivity’ to 
graded stimuli of different types (auditory, visual and proprioceptive stimuli), ‘motor 
reactivity’ and ‘grip strength’ were assessed. 
(B) Terminal Studies(34): 
Laboratory Investigations: Following laboratory investigations were carried out on day 29 in 
animals’fasted over-night. On 29th day, the animals were fasted for approximately 18 h, 
then slightly anesthetized with ether and blood samples were collected from the retro-orbital 
plexus into two tubes: one with EDTA for immediate analysis of haematological parameters, 
the other without any anticoagulant and was centrifuged at 4000 rpm at 4 °C for 10 minutes to 
obtain the serum. Serum was stored at 20 °C until analyzed for biochemical parameters.On 
28th day of the experiment, 24 h urine samples were collected by placing the animals in the 
metabolic cage with free access to tap water but no feed was given. 
Haematological Investigations: Blood samples of control and experimental rats was analyzed 
for hemoglobin content, total red blood corpuscles (RBC), white blood corpuscles (WBC) 
count, Mean corpuscular volume (MCV) and platelets. Then the mean values are calculated. 
Biochemical Investigations: Serum and Urine was used for the estimation of biochemical 
parameters. Samples of control and experimental rats were analyzed for protein, albumin, 
globulin,  bilirubin, urea, uric acid, creatinine, potassium, chlorine and sodium levels was 
carried using standard methods. Activities of glutamate oxaloacetate transaminase/ Aspartate 
aminotransferase (GOT/AST), glutamate pyruvate transaminase/ Alanine amino transferase 
(GPT/ALT) and alkaline phosphatase were estimated as per the colorimetric procedure. 
Urine analysis: Urine samples were collected in week 4 and in week 6 and for estimation of 
normal parameters.  
Necropsy:All the animals were sacrificed on day 29. Necropsy of all animals was carried out 
and the weights of the organs including liver, kidneys, adrenals, spleen, brain, heart, uterus and 
testes/ovaries were recorded 
Histopathology:Histopathological investigation of the vital organs was done. The organ pieces 
(3-5µm thick) of the highest dose level of 400 mg/kg were preserved and were fixed in 10% 
formalin for 24 h and washed in running water for 24 h. Samples were dehydrated in an auto 
technic and then cleared in benzene to remove absolute alcohol.  Embedding was done by 
passing the cleared samples through three cups containing molten paraffin at 50°C and then in 
a cubical block of paraffin made by the “L” moulds. It was followed by microtome and the 
slides were stained with Haematoxylin-eosin. The organs included brain, heart, kidneys, liver, 
lungs, spleen, and uterus of the animals were preserved they were subjected to 
histopathological examination. 
Statistical analysis: Findings such as clinical signs of intoxication, body weight changes, food 
consumption, hematology and blood chemistry were subjected to One-way Anova followed by 
dunnet’t’ test using a computer software programme -INSTAT-V3 version. 
 
 
 
PHARMACOLOGICAL STUDIES 
ANTIFERTILITY IN FEMALES: 
Invivo studies: 
 To study the antifertility effect of ethanolic  extract of mirabilis jalapa linn  on female 
albino wistar rats.. 
Estrogenic and Antiestrogenic Activity(35) 
 Animals: 
Female albino rats (Wistar strain weighing 150-200 g)were used for  the study.. The 
animals were housed in standard condition of temperature at 22±10 c,relative  humidity 55 
±10%  and a 12-h light dark cycle. The rats were acclimatized to laboratory hygienic 
conditions for 10 days before stating the experiment. Permission for Animals studies from 
Institutional Animal Ethics Committee (Ref: KKCP/2015/038) have been obtained at  K.K. 
College of Pharmacy,Gerugambakkam Chennai. 
 Grouping of Animals: 
Group I received 0.2 ml of distilled water orally and Group II  served as a standard 
received Ethinyl Estradiol  0.02mg/kg/rat per day  orally for 7 days. Group III and 
Group Iv received  200mg  and 400mg/kg of body weight of ethanolic extract of 
Mirabilis jalapa and  Group v and Group VI received  200mg  and 400mg/kg of body 
weight of ethanolic extract of Mirabilis jalapa and Ethinyl Estradiol  0.02mg/kg/rat. 
 
 Experimental Design(36,37): 
All the above treatments were given for 7 days. On 8th day, the rats were sacrificed by 
ether anesthesia  and uteri was dissected out and the surrounding tissue was 
removed.The tissue were dehydrated and embedded in paraffin.The final body weight, 
vaginal opening and vaginal cornification of all the rats were observed before 
anaesthesia and uterus of all the animals were weighed quickly on a sensitive 
balance(38).  
 
 Statistical Analysis: 
All the data were expressed as Mean ±SEM Statistical analysis was carried out by 
student’s t-test. 
 
 ABORTIFACIENT ACTIVITY(43) 
Animals: 
 
The female rats in proestrous phase  were  caged with males of proven fertility in the 
ratio 2:1 ,and examined the following day for the evidence of copulation. The rats 
having thickclump of spermatozoa in their vaginal smear were separated and it was 
considered as first day of Pregnancy. 
Female rats at 1st day of pregnancy were divided into three groups, consisting of six 
animals in each group. The animals were laparotomized under light ether anesthesia and 
semi-sterile conditions on 10th day of pregnancy. Both horns of the uterus were 
observed for the number of implants. The rats were sutured and allowed to recover then 
the animals were grouped. 
Grouping of Animals: 
Group I received 0.2 ml of distilled water, Group II received 0.2 mg ethinyl estradiol 
and Group III received 200 mg/kg and Group IV received 400 mg/kg.Animals were 
observed for vaginal bleeding from day 10 to 18th of pregnancy.On 21st Day animals are 
laparotomised under thiopentone sodium anesthesia. Both horns of the uterus are 
observed for the number of implantation sites ,resorptions ,dead and alive fetuses. 
 
Statistical Analysis: 
 
All the data were expressed as Mean ±SEM Statistical analysis was carried out by 
student’s t-test.  
 
 
 
 
 
 
 
 
 ANTIOVULATORY ACTIVITY(41) 
 
Animals: 
Female albino rats (Wistar strain weighing 150-200 g)were used for  the study.. The 
animals were housed in standard condition of temperature at 22±1oC,relative  humidity 
55 ±10%  and a 12-h light dark cycle. The rats were acclimatized to laboratory hygienic 
conditions for 10 days before stating the experiment.Vaginal smear from each rat is 
examined daily for 15 days, and those rats exhibited three regular cycleswere included 
in the study.The selected animals were divided into 4 groups. 
 
Grouping of Animals: 
Group I received 0.2 ml of distilled water. Group II served as a standard received 
(ethisterone), Group III and Group IV received 200mg and 400mg/kg of body weight of 
ethanolic extract of mirabilisjalapa. 
 
Vaginal Smear Observation(42) 
One drop of vaginal secretion was collected every morning between 9.A.M and 10 
A.M. Plastic pipette filled with 10µl 0.9% NaCl were inserted into rat vagina. Collected 
vaginal fluid were stained with methylene blue (aqueous) staining solution. Individual 
for each rat separate pipette tip and glass slide were used staining, slides were washed 
and dried. Stained material was observed through binocular microscope attached with 
monitor,under 10x objective lens. On observation, it was found that nucleated round 
cells were epithelial cells, little round cells were leucocytes and irregular cells without 
nucleus were cornified cells. Determination of the estrus cycle phases was inferred by 
the mutual proportion of cells Vaginal smear from each animal was observed every 
morning between 9–10 A.M for five days of treatment and subsequently for 15 days.ry 
morning between 9-10 A.M for five days of treatment and subsequently for 15 days. 
 
 
 
 
 
Weight of Ovaries and Uterus 
After the completion of experiments, the animals were sacrificed under thiopentone 
anaesthesia. Uteri and ovaries were dissected, removed of extra fat and weighed on 
sensitive balance  
 
Tissue Cholesterol Determination 
For tissue cholesterol estimation, one of the two ovaries from each rat was used for 
tissue cholesterol estimation. The ovarian tissue was homogenized in ice cold saline in 
a ratio of 1:60 to get an uniform suspension, using T-10 basic homogenizer with 
stainless steel disperser (S10N-10G). It was then centrifuged at 1000 rpm for 5 minutes. 
Cholesterol was estimated using total cholesterol ppt. set. The results were expressed in 
µg/ml of ovary 
 
REVERSIBLE ANTI-FERTILITY ACTIVITY OF FEMALE WISTAR RATS 
(45, 46) 
Animals: 
Female albino rats (Wistar strain weighing 150-200 g)were used for  the study.. The 
animals were housed in standard condition of temperature at 22±10 c,relative  humidity 
55 ±10%  and a 12-h light dark cycle. The rats were acclimatized to laboratory hygienic 
conditions for 10 days before stating the experiment. 
Grouping of Animals(47): 
Three groups of mature female rates (five rat/group) were selected for received extracts 
for 8 days, and control group received vehicle for the same period. All the experimental 
rats were then allowed to mate with mature fertile male rat and the treatment continued 
for 21 days. The number of litters was determined after the completion of one gestation 
period in all-experimental groups. The litters were allowed to grow and the growth of 
litters produced from the extract-administered group was compared with those of 
control group. The reversibility of anti-fertility effect of the extracts was also studied in 
the treated groups. For this study, the extracts were administered continuously for 21 
days, and then, the extract was withdrawn.  
 
 
 
 
After 21 days of extracts withdrawal, animals were allowed to mate with male rate. The 
number of litters was determined after the completion of one gestation period. 
Statistical Analysis: 
All the data were expressed as Mean ±SEM Statistical analysis was carried out 
bystudent’s t-test.  
 
ANTI –IMPLANTATION ACTIVITY(39,44): 
Animals: 
Proven fertile female rats of Wister strain weighing 200-250g were screened for 2-3 
estrous cycles by examining the vaginal smears. The rats that showed normal cycles for 
two successive examinations were selected for study.The rats in proestrus and estrous  
stage s were caged with fertile male in the ratio 2:1.The following dayvaginal smear 
were examined and the appearance of sperm clusters in the smears was recorded as day 
1 of pregnancy. 
Grouping of Animals: 
The animals were divided into four groups containing six animals in each group.Group 
I  served as control group received  distilled water . Group II served as a standard 
received Ethinyl Estradiol  0.02mg/kg/rat per day . Group III and Group Iv received  
200mg  and 400mg/kg of body weight of ethanolic extract of mirabilis jalapa. 
Experimental Design(40):.  
On 10th day of pregnancy, the animals are laparotomized  to find 0ut number of 
implants present in both the uterine horns ,.number of corpora lutea on the both ovaries 
is counted..Each pup is weighed and examined for gross defect.Weight gained by each 
rat of all the groups is recorded  
Biochemical studies: The present study besides evaluating the anti-implantation effect, 
also attempts to investigate some biochemical parameters, mainly blood glucose, 
cholesterol  and triglyceride. 
 
 
 
 
Statistical Analysis: 
All the data were expressed as Mean ±SEM Statistical analysis was carried out by 
student’s t-test.  
 
ANTIFERTILITY IN MALE ALBINO WISTAR RATS(48): 
 
ANTI-SPERMATOGENIC ACTIVITY: 
 
Animals: 
 
Male albino rats (Wistar strain weighing 150-200 g)were used for  the study. The animals 
were housed in standard condition of temperature at 22±10 c,relative  humidity 55 ±10%  
and a 12-h light dark cycle. The rats were acclimatized to laboratory hygienic conditions 
for 10 days before stating the experiment. Permission for Animals studies from Institutional 
Animal Ethics Committee (Ref: KKCP/2015/038) have been obtained at  K.K. College of 
Pharmacy, Gerugambakkam Chennai. 
 
Grouping of Animals(49,50): 
 
The animals were divided into four groups with six animals in each group.Group I control 
group.Group II received lonidamine 50mg/rat/day/p.o .Group III and IV received 200 and 
400mg ethanolic extract of mirabilis jalapa. 
 
Parameters 
Sex Hormones Estimation : Serum Levels of Sex Hormones(estimation of testosterone, 
prolactin and luteinizing hormone) were estimated by way of collecting blood samples 
from rats.  
 
Assessment of Sperm Mortility and Count : 
Progressive motility was tested immediately. The right cauda epididymids was incised and 
semen  was squeezed on a pre-warmed slide. Two drops of warm 2.9% sodium citrate was 
added to semen and mixed by a cover-slip. The percentage of progressive sperm motility 
was evaluated visually at 400x magnification. Motility estimates were performed from 
three different fields in each sample. The mean of te three successive estimations was used 
as the final motility score.  
 
For sperm count, the left cauda epididymidis was incised and semn that oozed was quickly 
sucked into a red blood pipette to the 0.5 mark, and then diluted with warm normal  saline 
upto 101 mark. A drop of the semen mixture was placed on the Neubauer counting 
chamber and viewed under the magnification of x40. The total numbers of sperm cells 
were counted and expressed as 106/ml. 
 
Assessment of Sperm Viability and Morphology:  
A viability study was done using eosin/nigrosin stain. A drop of semen was squeezed onto 
a microscope slide and two drops of the stain were added. Thin smears were then prepared 
and observed under a light microscope at x400 magnification. Viable sperm remained 
colorless while non-viable sperm stained red. The stained and the unstained sperm cells 
were counted using x40 microscope objectives and an average value for each was recorded 
from which percentage viability was calculated. 
 
To determine the percentage of morphologically abnormal spermatozoa, the slides stained 
with eosin-nigrosin(5 slides/rat) viewed under a light microscope at 400x magnifications. 
A total of 300 sperm cells was examined on each slide (1500 cells for each rat) and teh 
head, tail and total abnormality rates of spermatozoa were expressed as a percent. 
 
Body and Sex Weights: 
The initial and final body weights of the animals were recorded. The testes, epididymides, 
seminal vesicle and ventral prostate were dissected out, freed from adherent tissues and 
blood, and weighted to the nearest milligram. Organ weights were reported as relative 
weights(organ weight/body weight x 100). 
 
Quantification of fructose in seminal vesicle  
For Fructose quantification, seminal vesicular homogenate was prepared at a tissue 
concentration of 50 mg/mL. The supernatant(seminal plasma) was deproteinised by adding 
50µL of zinc sulphate and sodium hydroxide to make a total dilution of seminal plasma 
1:16, followed by centrifugation at 2500 rpm for 15 min. For fructose measurement, 
200µL of clear seminal plasma was used and the optical density of standard and samples 
were measured against blank at 470nm. The concentration of fructose was obtained by 
plotting the value in standard curve and the value expressed in the unit of µM/mL of 
seminal plasma. 
Measurement of some biochemical and blood parameters 
Blood samples were collected from the heart of each rat at the time of scarification into 
non-heparinized and heparinised tubes. Serum aspartate aminotransferase (AST), alanine 
aminotransferase(ALT), creatinine and urea in addition to red blood cell (RBC) count, 
total leucocytic count(TLC), haemoglobin(Hb) concentration and packed cell volume 
(PCV) were determined by methods. 
 
Reversible antifertilit activity: 
After 60 days of the treatment of 200mg and 400mg ethanolic extract of mirabilis jalapa 
the extract was withdrawn  for another 30days of the treatment for reversible antifertility 
activity. 
 
Fertility activity: 
Male rats from each group (randomly selected) were paired individually with 
two proven fertile females in estrous phase. Success of mating was confirmed by 
the presence of spermatozoa in the vaginal smear of the mated rats. The number 
of female rats pregnant,fertility success and male fertility index were studied. 
 
Statistical Analysis 
The values are expressed as mean ±SEM of six observation in each group, All groups were 
subjected to one-way analysis of variance (ANOVA), which was followed by Dunnett’s 
test. 
 
Invitro Anti-fertility Activity in Female Rats 
The rat showing estrous phase were selected sacrificed and the uterus was removed. One 
Horn of the uterus was mounted on the organ bath which containing De-Jalon’s solution 
and allowed to stabilize for 45 minutes. During this period 3 washings were made with 
fresh De-Jalon’s solution. Dose response curve was noted for the extract 0.1 – 6.4 mg was 
noted. Dose response curve was recorded oxytocin(0.05- 0.8µg) until a ceiling effect was 
observed. The response of the extract was compared with that of oxytocin. 
 INVITRO STUDIES(51): 
Spermicidal Test in Vitro 
The extract were diluted with physiological saline (9 mg/ml NaCl) serially up to 20.0, 10.0, 
and 5.0 mg/ml, respectively.. 
A spermicidal test was performed with each dilution,. The result was scored as momentary 
spermicidal activity in vitro  
Sperm HOS test and EY staining 
The HOS test was performed as recommended .A total of 0.1 ml of semen sample was 
mixed with 1.0 ml of a hypo-osmotic solution (150 mOsm). After incubation for 5 min, 
evaluating the modifications of the sperm tail to score swollen sperm (normal HOS) and 
unswollen sperm (abnormal HOS), which were reported as a percentage of all sperm 
observed. 
EY staining test: 
Sperm viability was determined by using a modified EY staining test. Live spermatozoa 
had white heads (EY unstained) and dead spermatozoa had heads that were stained red or 
dark pink (EY stained). 
SCD Test 
The SCD test performed The semen sample mixed with 0.1 ml of the extract from 
physiological saline was centrifuged at 1000 r/min for 10 min. The seminal plasma was 
discarded. 
Coverslips were carefully removed, and slides were immediately immersed horizontally in 
a tray with freshly prepared acid denaturation solution (0.08 mol/L HCl) for 7 min at 22 °C 
in the dark to generate restricted single-stranded DNA (ssDNA) motifs from DNA breaks.  
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
RESULTS AND ANALYSIS 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
V. RESULTS AND ANALYSIS 
RESULTS: 
 
Table 5.1 Preliminary Phyto-chemical screening of various extracts of leaves of Mirabilis 
jalapaLinn 
 
 
S.No Phyto 
Constituents 
Ethanol Acetone Petroleum 
ether 
Ethyl 
acetate 
Aqueous 
1 Alkaloids +++ +++ +++ +++ +++ 
2 Carbohydrates +++ +++ -- +++ ++ 
3 Tannins +++ -- -- -- ++ 
4 Terpenes +++ -- -- -- -- 
5 Soponins +++ -- -- -- ++ 
6 Glycosides +++ -- -- +++ -- 
 
 
 
+++ - Highly Present   + - Present 
 
 
++ - Moderately Present  - - Absent 
 
 
 
  
 
ACUTE ORAL TOXICITY STUDY: 
 
Acute Oral Toxicity Studies for the Ethanolic Extract of Mirabilis jalapa Linn 
 
 
There was no signs of toxicity up to 2000 mg/kg of the extract, it shows the absence of pilo 
erection, righting reflux, seizure, any stains of urine, loss of righting reflux, alopecia, edema, 
lacrimation etc 
 
 REPEATED DOSE 28-DAY SUB-ACUTE ORAL TOXICITY STUDY OF ETHANOLIC 
EXTRACT OF mirabilis jalapaLinn ON RATS (OECD – 407 GUIDELINES) 
 
Table 5.2:Body weight (g) of albino rats exposed to ethanolic extract of Mirabilis jalapa 
Linn for 28 days 
Dose 
(mg/kg/day) 
Days 
1 7 14 21 28 
Control 1 40.24±1.02 142.22±1.06 148.04±1.46 150.11±0.44 152.01±0.21 
200 144.11±0.01 142.24±1.65 140.22±1.21 138.20±0.11 136.12±0.01 
400 142.01±0.02 140.20±1.02 139.01±1.12 138.01±1.04 136.22±0.48 
 
Values are mean of a 6 animals ± S.E.M (Dunnet’s test) *p<0.05 ;**p<0.01.N=6 
 
 
Table 5.3.Water (ml/day) intake of albino rats exposed to for 28 days. 
 
Dose(mg/kg/day) 
Days(ml/rat) 
1 7 14 21 28 
Control 44.01±0.11 46.22±0.04 45.21±0.32 46.13±0.97 46.64±0.11 
200 48.42±0.63 52.08±0.14 55.67±0.12 58.20±1.24 60.12±1.02 
400 50.28±0.61 54.22±0.44 58.12±1.08 62.01±1.44 64.02±1.21 
Values are mean of a 6 animals ± S.E.M (Dunnet’s test) *p<0.05 ;**p<0.01.N=6 
Table 5.4.Food (g/day) intake of albino rats exposed to ethanolic extract of Mirabilis 
jalapaLinn for 28 days. 
 
Dose 
(mg/kg/day) 
Days (gms/rats) 
1 7 14 21 28 
Control 40.10±1.12 42.46±1.21 42.24±0.24 44.20±1.20 46.12±1.04 
200 42.20±0.44 45.28±0.18 47.22±1.02 50.16±1.02 52.11±0.22 
400 45.21±0.12 46.22±1.606 48.12±0.13 50.24±1.08 54.12±0.22 
Values are mean of a 6 animals ± S.E.M (Dunnet’s test)* p<0.05 ;**p<0.01.N=6 
 
 
Table 5.4.Hematological parameters after 28days treatment with ethanolic extract of  
Mirabilis jalapa Linn in rats 
 
Parameters Control 200mg/kg 400mg/kg 
Red blood 
cell(mm3) 
7.18±0.24 8.02±1.44 9.46±1.28 
HB(%) 14.22±0.10 15.42±0.28 16.48±1.0212 
Leukocyte 
(x106/ml) 
10144±200.12 10228±241.27 10302±252.24 
Platelets/ul 1432±21.22 1411±30.20 1462±32.01 
MCV(gl) 55.02±1.02 56.02±2.22 57.12±2.08 
 
Values are mean of a 6 animals ± S.E.M (Dunnet’s test)* p<0.05 ;**p<0.01.N=6 
 Table 5.6:Effect of treatment with ethanolic extract of mirabilis jalapaLinn on  
 
biochemical parameters: 
 
LFT 
Dose(mg/kg) Control 200mg/kg 400mg/kg 
Total 
Bilirubin(mg/dl) 
0.210±0.11 0.214±0.10 0.216±0.16 
Bilirubin 
direct(mg/dl) 
0.1±0.02 0.1±0.04 0.1±0.04 
Bilirubin 
indirect(mg/dl) 
0.1±00 0.1±00 0.1±00 
ALP(U/L) 382.02±10.22 360.46±10.12 340.12±12.04 
SGOT(U/L) 160.02±1.06 160.11±1.04 159.26±1.12 
SGPT(U/L) 46.14±0.20 46.20±0.24 46.46±0.02 
Total 
protein(g/dl) 
10.01±0.08 9.02±0.11 9.01±1.48 
Albumin(g/dl) 3.10±0.02 3.10±0.04 3.12±0.04 
Globulin(g/dl) 6.08±0.12 5.84±0.24 5.42±0.24 
 
 
Values are mean of a 6 animals ± S.E.M (Dunnet’s test)* p<0.05 ;**p<0.01.N=6 
Table 5.7:RFT 
 
 
Dose (mg/kg) Control 200(mg/kg) 400(mg/kg) 
Urea(mg/dl) 56.21±1.23 55.80±1.02 53.09±1.21 
Creatinine(mg/dl) 0.74±0.01 0.74±0.02 0.76±0.04 
Uric acid(mg/dl) 1.6±0.02 1.6±0.04 1.6±0.06 
Na m.mol 136.4±1.02 138.2±1.02 140.01±1.20 
K m.mol 18.01±1.14 19.02±1.08 19.42±1.22 
Cl m.mol 96.04±1.02 99.20±0.12 100.04±0.22 
 
 
Values are mean of a 6 animals ± S.E.M (Dunnet’s test) *p<0.05 ;**p<0.01.N=6. 
Table 5.8 Lipid Profile 
 
 
Parameters Control  200mg/kg 400mg/kg 
Blood glucose (mg/dl) 126.20±0.02 126.42±1.24 126.12±1.24 
Triglycerides(mg/kg) 80.12±1.22 79.12±1.01 78.11±0.14 
HDL(mg/dl) 12.08±1.02 12.44±1.20 12.88±1.28 
Total cholesterol (mg/kg) 40.20±1.01 38.24±1.24 38.16±1.28 
LDL(mg/dl) 38.10±1.04 40.12±1.42 40.00±1.04 
VLDL (mg/dl) 15.62±1.02 15.22±1.08 15.01±1.24 
TC/HDL ratio (g/dl) 2.02±0.22 2.44±1.20 3.12±0.04 
 
 
Values are mean of a 6 animals ± S.E.M (Dunnet’s test) *p<0.05 ;**p<0.01.N=6 
 
 
 
 Table 5.9:Urine Analysis 
 
 
Parameters Control 200mg/kg 400mg/kg 
Transparency Clear Slightly turbid Slightly turbid 
Specific gravity 1.010 1.010 1.010 
PH >7.2 >7.4 >7.4 
Protein Nil 2+ 2+ 
Glucose Nil Nil Nil 
Bilirubin -ve -ve -ve 
Ketones -ve -ve -ve 
Blood  Absent Absent Absent 
Urobilinogen Normal Abnormal Abnormal 
Pus cells 0-cells/HPF 0-cells/HPF 1-cells/HPF 
RBC Nil Nil 1-cells/HPF 
Epithelial cells Nil 1-cells/HPF Nil 
Crystals Nil Nil Nil 
Casts Nil Nil Nil 
Others Bacteria seen Bacteria seen Bacteria seen 
Colour yellow Yellow Yellow 
 
Values are mean of a 6 animals ± S.E.M (Dunnet’s test)* p<0.05 ;**p<0.01.N=6 
 
 
 
  
 
Table 5.10.Effect of oral administration of ethanolic extract of mirabilis jalapaLinn on  
 
Organ Weight 
 
 
 
Dose (mg/kg) Control 200mg/kg 400mg/kg 
Liver(g) 4.22±0.20 4.84±0.12 5.10±0.89 
Heart (g) 0.60±0.01 0.60±0.02 0.62±0.02 
Lung(g) 1.44±0.02 1.42±0.04 1.42±0.06 
Spleen (g) 0.54±0.02 0.54±0.04 0.56±0.08 
Ovary (g) 1.54±0.08 1.56±0.02 1.58±0.02 
Testes(g) 1.26±0.06 1.28±0.26 1.32±0.18 
Brain(g) 1.42±0.12 1.44±0.01 1.52±0.14 
Kidney(g) 0.64±0.01 0.66±0.02 0.68±0.02 
Stomach(g) 1.34±0.1 1.38±0.10 1.38±0.11 
 
 
Values are mean of a 6 animals ± S.E.M (Dunnet’s test) *p<0.05 ;**p<0.01.N=6 
 
 
 
 
HISTOPATHOLOGICAL STUDIES 
A) KIDNEY 
 
 
Control 
 
 
Mirabilis jalapa Linn (200 mg/kg) 
 
 
  
Mirabilis jalapa Linn (400 mg/kg) 
 
 
 
 
 
 
 
 
 
 
 
 
 
b) HEART 
 
CONTROL 
 
Mirabilis jalapa Linn (200 mg/kg) 
 
  
Mirabilis jalapa Linn (400 mg/kg) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
c) Liver 
 
 
 
CONTROL 
 
 
Mirabilis jalapa Linn (200 mg/kg) 
 Mirabilis jalapa Linn (400 mg/kg) 
 
 
 
 
 
 
 
 3. Spleen 
 
CONTROL 
 
 
Mirabilis jalapa Linn (200 mg/kg) 
  
Mirabilis jalapa Linn (400 mg/kg) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4. Stomach 
 
Control 
 
Mirabilis jalapa Linn (200 mg/kg) 
 
  
Mirabilis jalapa Linn (400 mg/kg) 
 
 
 
 
 
 
 
 
 
 
 
 
ANTIFERTILITY IN FEMALES: 
 
Table 5.11: Estrogenic and antiestrogenic activity of the ethanolic extract of Mirabilis  
jalapaLinn in rats. 
 
Groups Treatment Uterine weight 
(mg/100gm body 
weight) 
Vaginal 
cornification 
I Control(distilled water) 72.83±2.28 Vagina not open 
II Ethinyl 
estradiol(0.02mg/kg) 
179.01±2.29*** Open(+++) 
III EEMJ (200mg/kg) 104.5±4.18** Open(+ to++) 
IV EEMJ(400mg/kg) 142.2±2.16*** Open(+ to ++) 
V EEMJ(200mg/kg)+ethinyl 
estradiol(0.02mg/kg 
130.2±0.12** Open(+++) 
VI EEMJ(400mg/kg)+ethinyl 
estradiol(0.02mg/kg) 
158.6±0.22*** Open(+++) 
 
 
 
 
Statistical Analysis by Student t- test 
Values are mean ± SEM, n= 6 in each group 
Significantly different from control group *P<0.05, **P<0.01, ***P<0.001 
Significantly different when compared with ethinyl estradiol group aP<0.05, bP< 0.01, 
cP<0.001 
+ -nucleated epithelial cells, ++ -nucleated and cornified cells, +++ -cornified cells. 
 
Figure 5.1 Estrogenic and antiestrogenic activity of the ethanolic extract of 
 
 
Group I  : control group received
Group II  : standard received Ethinyl Estradiol  0.02mg/kg/rat per day  
Group III :received  200mg  of body weight of ethanolic extract of 
Group IV : received  200mg  and 400mg/kg of body weight of etha
jalapa  
Group V :received  200mg  of body weight of ethanolic extract of 
Estradiol  0.02mg/kg/rat 
Group VI :received  400mg  of body weight of ethanolic extract of 
Estradiol  0.02mg/kg/rat 
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Table 5.12Histological changes in the uterus and endometrium after treatment with the 
ethanolic extract of mirabilis jalapa in rats: 
 
Groups Treatment Diameter of the 
uterus(µm) 
Thickness of 
endometrium(µm) 
I Control(distilled water) 284.02±2.12 128.14±1.26 
II Ethinyl 
estradiol(0.02mg/kg) 
502.14±0.16** 360.20±0.24* 
III EEMJ (200mg/kg) 310.16±0.22* 248.12±2.84** 
IV EEMJ(400mg/kg) 420.28±2.28** 286.01±1.22** 
V EEMJ(200mg/kg)+ethinyl 
estradiol(0.02mg/kg 
431.67±3.14* 307.12±0.22* 
VI EEMJ(400mg/kg)+ethinyl 
estradiol(0.02mg/kg) 
470.84±1.02** 326.08±4.28* 
 
 
 
Statistical Analysis by Student t- test 
 
Values are mean ± SEM, n= 6 in each group 
 
Significantly different from control group *P<0.05, **P<0.01, ***P<0.001 
 
Significantly different when compared with ethinyl estradiol group aP<0.05, bP< 0.01, 
cP<0.001 
 Figure 5.2 Histological changes in the uterus and endometrium after treatment with the  
ethanolic extract of Mirabilis jalapa in rats: 
 
 
 
 
Group I  : control group received  0.2ml of  distilled water orally. 
Group II  : standard received Ethinyl Estradiol  0.02mg/kg/rat per day 
Group III  :received  200mg  of body weight of ethanolic extract of Mirabilis jalapa 
Group IV : received 400mg/kg of body weight of ethanolic extract of Mirabilis jalapa 
Group V :received  200mg  of body weight of ethanolic extract of Mirabilis jalapa + Ethinyl 
Estradiol  0.02mg/kg/rat 
Group VI :received  400mg  of body weight of ethanolic extract of Mirabilis jalapa + Ethinyl 
Estradiol  0.02mg/kg/rat 
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ANTI IMPLANTATION ACTIVITY 
 
Table 5.13:Changes in the body weight in the ethanolic extract of Mirabilis jalapa Linn 
 
S.No Treatment Dose 
mg/kg 
0 days 7 days 14days 21days 
I Control Distilled 
water 
184.01±1.02 186±0.21 188±0.12 192±0.16 
II Standard  Ethinyl 
estradiol 
187.5±0.22 185±1.21 183±0.24 180±1.10 
III MJ 200 190.12±1.24 189±0.67 187±1.64 180±0.10 
IV MJ 400 188.18±0.21 184±1.21 180±2.89 178±0.21 
 
 
 
Statistical Analysis by Student t- test 
 
 
Values are mean ± SEM, n= 6 in each group 
 
 
Significantly different from control group *P<0.05, **P<0.01, ***P<0.001 
 
 
Significantly different when compared with ethinyl estradiol group aP<0.05, bP< 0.01, 
cP<0.001 
 Figure 5.3 Changes in the body weight in the ethanolic extract of Mirabilis jalapa Linn 
 
 
 
 
 
 
 
Group I  : control group received  0.2ml of  distilled water orally. 
 
Group II  : standard received Ethinyl Estradiol  0.02mg/kg/rat per day   
 
Group III  :received  200mg  of body weight of ethanolic extract of Mirabilis jalapa 
 
Group IV : received 400mg/kg of body weight of ethanolic extract of Mirabilis jalapa 
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Table 5.14Effect of ethanolic extract of  Mirabilis jalapaLinn on  reduction  in  
pregnancy in rats 
 
 
S.No Treatment No of rats 
pregnant/treated 
% 
reduction 
in 
pregnancy 
No of 
implant in 
individual 
rats 
No of rats  
delivered 
I Control 6/6 0 4,6,10.11.8.6 8(4,6,10,11,8,6) 
II Standard 
(Ethinyl Estradiol) 
0/6 100 0,0,0,0,0,0,0 0(0,0,0,0,0,0) 
III MJ(200 mg/kg) 3/6 50 3,0,2,8,0,4 2(3,0,2,8,0,4) 
IV MJ(400 mg/kg) 0/6 100 0,0,0,0,0,0,0 0(0,0,0,0,0,0) 
 
 
 
Statistical Analysis by Student t- test 
 
Values are mean ± SEM, n= 6 in each group 
 
Significantly different from control group *P<0.05, **P<0.01, ***P<0.001 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4 Effect of ethanolic extract of  mirabilis jalapa  on  reductio
rats 
 
 
 
 
 
 
Group I  : control group received  0.2ml of  distilled water orally.
Group II  : standard received Ethinyl Estradiol  0.02mg/kg/rat per day  
Group III  :received  200mg  of body 
Group IV : received 400mg/kg of body 
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5.15 Effect of ethanolic extract of mirabilis jalapa on blood glucose,cholesterol and  
 
triglycerides. 
 
S.No Treatment Dose mg/kg Blood glucose cholestrol Triglycerides 
I Control Distilled 
water 
72.14±0.04 70.12±1.04 158.12±1.02 
II Standard Ethinyl 
estradiol 
70.94±1.86*** 50.24±0.28*** 130.22±0.11*** 
III MJ 200 71.24±0.84** 56.16±0.01** 142.81±0.01** 
IV MJ 400 70.80±1.24*** 54.32±1.01*** 132.01±0.04*** 
 
 
Statistical Analysis by Student t- test 
 
Values are mean ± SEM, n= 6 in each group 
 
Significantly different from control group *P<0.05, **P<0.01, ***P<0.001 
 
Significantly different when compared with ethinyl estradiol group aP<0.05, bP< 0.01, 
cP<0.001 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.5 Effect of ethanolic extract of mirabilis jalapa on blood glucose,cholesterol and 
triglycerides. 
 
 
 
 
Group I  : control group received  0.2ml of  distilled water orally. 
Group II  : standard received Ethinyl Estradiol  0.02mg/kg/rat per day   
Group III  :received  200mg  of body weight of ethanolic extract of mirabilis jalapa 
Group IV : received 400mg/kg of body weight of ethanolic extract of mirabilis jalapa  
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3.Anti-Ovulatory activity: 
 
Table 5. 16 Effect of ethanolic extract of mirabilis jalapa Linnon the estrus cycle  
 
 
Group Treatment Estrous 
cycle(days) 
Proestrus Estrous Metastrus Diestrus 
I Control 4.48±0.10 0.86±0.11 0.92±0.14 0.82±1.40 2.01±0.14 
II Standard 6.44±0.60 0.50±1.28 1.92±0.01 0.48±1.22 3.92±1.21** 
III 200mg 5.48±1.20 0.68±0.12 1.30±1.46 0.62±1.48 3.38±0.11* 
IV 400mg 6.20±0.12 0.52±0.10 1.86±0.12 0.58±0.12 3.85±0.12** 
 
 
 
Statistical Analysis by Student t- test 
 
Values are mean ± SEM, n= 6 in each group 
 
Significantly different from control group *P<0.05, **P<0.01, ***P<0.001 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.6 Effect of ethanolic extract of Mirabilis jalapaLinn on the estrus cycle  
 
 
 
 
 
 
 
 
Group I  : control group received  0.2ml of  distilled water orally. 
Group II  : standard received Ethinyl Estradiol  0.02mg/kg/rat per day   
Group III  :received  200mg  of body weight of ethanolic extract of Mirabilis jalapa Linn. 
Group IV : received 400mg/kg of body weight of ethanolic extract of Mirabilis jalapaLinn 
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Table 5.17 Effect of Ethanolic extract of Mirabilis jalapaLinn on Ovary and Uterine 
Weight 
 
 
Group Treatment Ovarian Weight 
(gm) 
Uterine 
weight(mg/100g) 
I Control 42.12±0.18 212.12±0.14 
II Standard 128.20±0.16 810.10±0.14 
III 200(mg/kg) 101.80±0.01 412.82±0.12 
IV 400(mg/kg) 122.14±0.14 780.48±1.68 
 
 
 
Statistical Analysis by Student t- test 
 
Values are mean ± SEM, n= 6 in each group 
 
Significantly different from control group *P<0.05, **P<0.01, ***P<0.001 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
Figure 5.7 Effect of ethanolic extract of Mirabilis jalapa Linn on ovary and uterine  
 
weight 
 
 
 
 
 
 
 
 
 
Group I  : control group received  0.2ml of  distilled water orally. 
Group II  : standard received Ethinyl Estradiol  0.02mg/kg/rat per day   
Group III  :received  200mg  of body weight of ethanolic extract of Mirabilis jalapa Linn. 
Group IV : received 400mg/kg of body weight of ethanolic extract of Mirabilis jalapaLinn. 
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Table 5.18 Effect of Ethanolic extract of Mirabilis jalapa Linnon biochemical change  
 
in Ovary and Uterus. 
 
 
Group Treatment Organ type Protein(mg/kg) Cholestrol(mg/kg) 
I control Uterus 242.12±0.61 544.01±1.02 
Ovary 88.24±1.40 220.12±1.26 
II standard uterus 116.2±1.28 301.02±0.12 
ovary 86.14±1.20 172.12±0.84 
III 200mg uterus 128.12±1.01 296.14±0.11 
ovary 86.48±0.12 176.82±1.12 
IV 400mg uterus 120.20±1.12 310.12±1.42 
 
ovary 84.12±4.10 180.28±0.14 
 
 
Statistical Analysis by Student t- test 
 
Values are mean ± SEM, n= 6 in each group 
 
Significantly different from control group *P<0.05, **P<0.01, ***P<0.001 
  
 
 
 
Figure 5.8 Effect of Ethanolic extract of Mirabilis jalapa on biochemical change in  
 
Ovary 
 
 
 
 
 
 
 
 
Group I  : control group received  0.2ml of  distilled water orally. 
Group II  : standard received Ethinyl Estradiol  0.02mg/kg/rat per day   
Group III  :received  200mg  of body weight of ethanolic extract of Mirabilis jalapa Linn. 
Group IV : received 400mg/kg of body weight of ethanolic extract of Mirabilis jalapaLinn 
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Figure 5.9 Effect of Ethanolic extract of Mirabilis jalapa on biochemical change in  
 
uterus 
 
 
 
 
 
 
 
Group I  : control group received  0.2ml of  distilled water orally. 
Group II  : standard received Ethinyl Estradiol  0.02mg/kg/rat per day   
Group III  :received  200mg  of body weight of ethanolic extract of Mirabilis jalapa Linn 
Group IV : received 400mg/kg of body weight of ethanolic extract of Mirabilis jalapaLinn 
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Reversible antifertility : 
 
Table 5.19 Effect of ethanolic extract of  Mirabilis jalapaLinn  on  reduction  in 
pregnancy in rats 
 
 
S.No Treatment No of rats 
pregnant/treated 
% 
reduction 
in 
pregnancy 
No of 
implant in 
individual 
rats 
No of rats  
delivered 
I Control 6/6 0 4,6,10.11.8.6 8(4,6,10,11,8,6) 
II Standard 
(Ethinyl Estradiol) 
0/6 100 0,0,0,0,0,0,0 0(0,0,0,0,0,0) 
III MJ(200 mg/kg) 3/6 50 3,0,2,8,0,4 2(3,0,2,8,0,4) 
IV MJ(400 mg/kg) 0/6 100 0,0,0,0,0,0,0 0(0,0,0,0,0,0) 
 
 
 
 
 
Statistical Analysis by Student t- test 
 
Values are mean ± SEM, n= 6 in each group 
 
Significantly different from control group *P<0.05, **P<0.01, ***P<0.001 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.10 Effect of Ethanol
 
 
 
 
 
 
Group I  : control group received  0.2ml of  distilled water orally.
Group II  : standard received Ethinyl Estradiol  0.02mg/kg/rat per day  
Group III  :received  200mg  of bo
Group IV : received 400mg/kg of body 
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 5.20 Effect of ethanolic extract of Mirabilis jalapa Linn on Blood Glucose, Cholesterol  
 
andTriglycerides. 
 
 
 
 
S.No Treatment Blood 
Glucose(mg/dl) 
Cholestrol 
(mg/kg) 
Triglycerides 
(mg/kg) 
I Control 72.14±0.04 70.12±1.04 158.12±1.02 
II Standard 
(Ethinyl Estradiol) 
70.94±1.86 50.24±0.28 130.22±0.11 
III MJ(200 mg/kg) 71.24±0.84 56.16±0.01 142.81±0.01 
IV MJ(400 mg/kg) 70.80±1.24 54.32±1.01 132.01±0.04 
 
 
Statistical Analysis by Student t- test 
 
Values are mean ± SEM, n= 6 in each group 
 
Significantly different from control group *P<0.05, **P<0.01, ***P<0.001 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 5.11 Effect of ethanolic extract of Mirabilis jalapaLinn on blood glucose, 
 
cholesterol and triglycerides 
 
 
 
 
Group I  : control group received  0.2ml of  distilled water orally. 
Group II  : standard received Ethinyl Estradiol  0.02mg/kg/rat per day   
Group III  :received  200mg  of body weight of ethanolic extract of Mirabilis jalapa Linn 
Group IV : received 400mg/kg of body weight of ethanolic extract of Mirabilis jalapaLinn 
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4.  Abortifacient Activity 
 
Table5.21 Effect of Ethanolic extract of Mirabilis jalapa linn on Abortifacient Activity in 
Female Rats 
Treatment 
 
Body 
Weight 
Drug 
Dose 
(mg/kg  
Body 
weight) 
Noof Fetus 
IndividualRa
ts on  
Day 10 
No of Rats 
Delivered 
(little size) 
Noof re-
Absorption in 
Individual Rats 
No of re-
absorption in 
Mean±SEM 
% 
Abortifacient 
Activity 
Group I 140-210 Distilled 
Water 
8,7,8,6,8,9 6(8,11,8,6,8,9) 0,0,0,0,0,0 0 Nil 
Group II 140-220 Ethinyl 
Estradiol 
(0.02) 
8,9,8,10,11,6 6(0,0,0,0,0) 8,9,8,10,11,6 8.66±0.08 100 
Group III 140-210 EEMJ 
200mg/kg 
8,10,11,9,8,9 6(4,8,7,5,4,7) 4,2,3,4,4,2 4.0±0.14 43.01 
Group IV 140-220 EEMJ 
400mg/kg 
14,7,8,6,9,9 6(0,0,0,0,0,0) 14,7,8,6,9,9 8.83±0.28 100 
 
Statistical Analysis by Student t- test 
 
Values are mean ± SEM, n= 6 in each group 
 
Significantly different from control group *P<0.05, **P<0.01, ***P<0.001 
 
Significantly different when compared with ethinyl estradiol group aP<0.05, bP< 0.01, 
cP<0.001 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.12 Effect of ethanolic extract of Mirabilis jalapa linn on abortifacient activity  
 
in female rats 
 
 
 
 
 
 
Group I  : control group received  0.2ml of  distilled water orally. 
Group II  : standard received Ethinyl Estradiol  0.02mg/kg/rat per day   
Group III  :received  200mg  of body weight of ethanolic extract of Mirabilis jalapa Linn. 
Group IV : received  200mg  and 400mg/kg of body weight of ethanolic extract of Mirabilis 
jalapaLinn. 
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Reversible antifertility activity: 
 
 
Table 5.22 Effect of extracts on reproductive outcome: 
 
 
Groups Oestrous Cycle Fertility Litters Present 
control Regular 100./.+ve 10.00±0.1 
standard Irregular 7.4./.-ve 5.20±0.12 
MJ 200mg/kg Irregular 8.1./.-ve 6.42±1.90* 
MJ400mg/kg Irregular 7.8./.-ve 5.68±1.22** 
Withdrawal-MJ 
200mg/kg 
Regular 82.0./.+ve 8.42±0.02* 
Withdrawal MJ 
400mg/kg 
Regular 85.4./.+ve 8.66±0.21** 
 
 
Statistical Analysis by Student t- test 
 
Values are mean ± SEM, n= 6 in each group 
 
Significantly different from control group *P<0.05, **P<0.01, ***P<0.001 
 
Significantly different when compared with ethinyl estradiol group aP<0.05, bP< 0.01, 
cP<0.001 
 
 
 
 
 
 
 
 
 
 
  
Table 5.23 Hormonal Level in various groups of animals 
 
Treatment LH FSH Prolactin 17 β estradiol 17-OH 
progesterone 
Control 6.12±0.12
 
8.22±5.10 40.14±3.20 720.12±12.10 14.12±2.12 
Standard 4.01±1.21 4.01±0.05 38.01±2.20 501.20±10.12 25.08±0.01 
MJ(200mg/kg) 5.86±0.42 6.20±5.82 40.86±0.21 580.16±10.01 22.16±1.21 
MJ(400mg/kg) 4.24±0.01 4.01±1.20 38.02±1.20 523.01±0.12 28.01±1.20 
 
Values are mean ± SEM, n= 6 in each group 
 
Significantly different from control group *P<0.05, **P<0.01, ***P<0.001 
 
Significantly different when compared with ethinyl estradiol group aP<0.05, bP< 0.01, 
cP<0.001 
 
 
 
 
 
 
 
 
 
 
Figure 5.13 Effect of mirabilis jalapa on Hormonal Level  of animals 
 
 
Group I  : control group received  0.2ml of  distilled water orally. 
Group II  : standard received Ethinyl Estradiol  0.02mg/kg/rat per day   
Group III  :received  200mg  of body weight of ethanolic extract of Mirabilis jalapa Linn 
Group IV : received  200mg  and 400mg/kg of body weight of ethanolic extract of 
MirabilisjalapaLinn 
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Figure 5.14 Effect of Mirabilis jalapa
 
Group I  : control group received  0.2ml of  distilled water orally.
Group II  : standard received Ethinyl Estradiol  0.02mg/kg/rat per day  
Group III  :received  200mg  of body 
Group IV : received  200mg  and 400mg/kg of body 
jalapa Linn. 
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 ANTIFERTILITY IN MALES: 
 
 
Antispermatogenic Activity 
 
Table 5.24:Effect of Mirabilis JalapaLinn on body weight and reproductive organ weight 
of male albino rats 
Group Treatment Body Weight Reproductive Organ Weight 
(mg/100gm body weight) 
Initial Final Difference Testes Seminal 
Vesicle 
Vas 
Defence 
Prost
ate 
Epidymis 
Group I  Control 
(distilled 
water 
182.10 
±1.22 
220.12 
±0.13 
38.02 1250.04 
±20.22 
444.81 
±11.41 
180.12 
±10.12 
70.12
±0.22 
281.22 
±1.01 
Group II Standard drug 
(lonidamine 
50mg) 
179.29 
±1.01 
200.17 
±0.28 
20.88 823.09 
±44.12 
250.12 
±10.24 
120.42 
±1.33 
40.43
±0.51 
180.12 
±2.02 
Group III 200mg/kg 178.04 
±1.22 
212.11 
±1.01 
34.07 994.13 
±12.11 
320.22 
±24.12 
172.22 
±1.22 
63.67
±1.08 
224.11 
±1.02 
Group IV 400mg/kg 181.10 
±1.22 
205.22 
±0.12 
24.12 850.43 
±10.22 
272.42 
±1.09 
128.72 
±2,08 
41,21
±1.43 
184.22 
±1.09 
 
Values are expressed as mean ±S.E of six rats for each group. 
P<0.05 * p>0.01** p>0.001***statistically significant from control (dunnett’s test. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.15 :Effect of Mirabilis Jalapa on body weight and reproductive organ weight 
of Male Albino Rats 
 
 
 
 
Group I  : control group received  0.2ml of  distilled water orally. 
Group II  : standard received Lonidamine 50mg/kg/rat per day   
Group III  :received  200mg  of body weight of ethanolic extract of mirabilis jalapa 
Group IV : received  200mg  and 400mg/kg of body weight of ethanolic extract of mirabilis 
jalapa  
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Table 5.25 :Effect of Mirabilis Jalapa on body weight and vital  organ weight of male 
albino rats 
Groups Treatment Body weight vital organ weight(mg/100gm body weight) 
Initial Final Difference liver heart kidney Adrenal 
gland 
 
Group I  Control 
(distilled water) 
182.10
±1.22 
220.12
±0.13 
38.02 3402.33
±1.01 
340.12
±0.11 
390.13±1.67 25.98±0.12 
Group II Standard 
drug(lonidamine 
50mg) 
179.29
±1.01 
200.17
±0.28 
20.88 3501±0.
12 
338.19
±1.32 
382.24±1.01 27.12±0.22 
Group 
III 
200mg/kg 178.04
±1.22 
212.11
±1.01 
34.07 3420±1.
07 
340.17
±2.01 
386.11±1.08 25.02±1.12 
Group 
IV 
400mg/kg 181.10
±1.22 
205.22
±0.12 
24.12 3470±2.
10 
332.26
±1.02 
390.42±0.14 25.19±1.34 
 
Values are expressed as mean ±S.E of six rats for each  group. 
P<0.05 * p>0.01** p>0.001***statistically significant from control (dunnett’s test. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 5.16 Effect of Mirabilis Jalapa on body weight and vital organ weight of male 
albino rats 
 
 
 
Group I  : control group received  0.2ml of  distilled water orally. 
Group II  : standard received Lonidamine 50mg/kg/rat per day   
Group III  :received  200mg  of body weight of ethanolic extract of Mirabilis jalapa Linn 
Group IV : received  200mg  and 400mg/kg of body weight of ethanolic extract of Mirabilis 
jalapaLinn 
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 Table 5.26 Effect of  Oral Administrata of Mirabilis jalapaLinn on Serum Level of 
reproductive hormones of male rats (n=6) 
 
 
 
Group Doses 
mg/kg 
Testosterone 
ng/ml 
Prolactin 
.ng/ml 
FSH 
(mIU/mL) 
LH 
(mIU/mL) 
Control 00 4.24±0.12 0.88±1.02 7.28±0.12 0.64±1.12 
Standard 50 2.32±1.16 1.86±1.04 4.40±1.12 0.30±1.12 
EEMJ 200 3.28±1.14 1.52±2.01 5.14±0.89 0.46±0.02 
EEMJ 400 2.40±0.12 1.82±0.12 4.62±0.12 0.33±0.12 
 
 
 
 
Vales represent the mean ±S.E. of six rats for each group 
 
. P<0.05 statistically significant from control (Dunnett’s Test). 
 
P<0.001 statistically significant from control (Dunnett’s Test) 
 
 
 
 
 
 
 
 
 
 
 
 5.17 Effect of Oral Administration of Mirabilis jalapaLinn on Serum Level of 
reproductive hormones of male rats  
 
 
 
 
 
 
Group I  : control group received  0.2ml of  distilled water orally. 
Group II  : standard received Lonidamine 50mg/kg/rat per day   
Group III  :received  200mg  of body weight of ethanolic extract of Mirabilis jalapa Linn. 
Group IV : received  200mg  and 400mg/kg of body weight of ethanolic extract of Mirabilis 
jalapaLinn. 
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 Figure 5.18 Effect of Oral Administrata of Mirabilis jalapaLinn on Serum Level of 
reproductive hormones of male rats  
 
 
 
 
 
 
 
Group I  : control group received  0.2ml of  distilled water orally. 
Group II  : standard received Lonidamine 50mg/kg/rat per day   
Group III  :received  200mg  of body weight of ethanolic extract of Mirabilis jalapa Linn. 
Group IV : received  200mg  and 400mg/kg of body weight of ethanolic extract of 
Mirabilisjalapa Linn. 
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 Table 5.27 Effect of Oral administrative of Mirabilis jalapa Linn on Semen 
Characteristics and Fructose Content in Seminal Vesicle of Male Rats  
 
Group Doses 
(mg/kg) 
Sperm 
Count 
(x106/mL) 
Sperm 
Motility (%) 
Sperm 
Viability 
(%) 
Fructose 
Level 
(µM/mL) 
Control 0.2ml 50.1±0.14 89.4±2.2
 
84.4±1.2 4.62±0.12 
Standard 50 28.1±1.14*** 52.4±0.4***
 
58.2±0.14** 2.16±0.12** 
EEMJ 200 34.2±0.12 64.2±1.2 66.2±3.2* 2.95±1.20* 
EEMJ 400 30.4±0.01*** 58.8±0.1*** 60.4±1.2** 2.70±1.02** 
 
 
 
Vales represent the mean ±S.E. of six rats for each group 
 
P<0.05 * p>0.01** p>0.001***statistically significant from control (dunnett’s test. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.19 Effect of Oral administrative of Mirabilis jalapa Linn on Semen 
Characteristics and Fructose Content in Seminal Vesicle of Male Rats  
 
 
 
 
 
 
 
 
Group I  : control group received  0.2ml of  distilled water orally. 
Group II  : standard received Lonidamine 50mg/kg/rat per day   
Group III  :received  200mg  of body weight of ethanolic extract of Mirabilis jalapa Linn. 
Group IV : received  200mg  and 400mg/kg of body weight of ethanolic extract of Mirabilis 
jalapaLinn. 
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Figure 5.20 Effect of Oral administrative of Mirabilis jalapa Linn on Semen 
Characteristics and Fructose Content in Seminal Vesicle of Male Rats  
 
 
 
 
 
 
Group I  : control group received  0.2ml of  distilled water orally. 
Group II  : standard received Lonidamine 50mg/kg/rat per day   
Group III  :received  200mg  of body weight of ethanolic extract of Mirabilis jalapa Linn. 
Group IV : received  200mg  and 400mg/kg of body weight of ethanolic extract of Mirabilis 
jalapaLinn. 
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Table 5.28 Effect of Oral Administrative of Mirabilis jalapa Linn extract on  ating trial 
of male rats with normal untreated females (mating ration – 1 male:2 females) 
 
Group Doses 
(mg/kg) 
No.of 
Females 
mated 
Mating 
Success 
% 
No of 
females 
pregnant 
Fertility 
Success, 
% 
Male 
Fertility 
Index (%) 
Control 00 12/12 100 12/12 100 100 
Standard 
(Lonidamine) 
50 7/12 58.33 5/12 41.66 71.42 
EEMJ 200 7/12 75.00 6/12 50.00 85.00 
EEMJ 400 6/12 50.00 5/12 41.66 83.33 
 
Data are expressed as numbers and % of 6 males and 12 females. 
 
Evidenced by Vaginal Plug and Sperm in a Vaginal Smear. 
 
Male Fertility Index {(number pregnant/number mated)x100} 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Figure 5.21 Effect of Oral Administrative of Mirabilis jalapa Linn extract on  mating trial of 
male rats with normal untreated females (mating ration – 1 male:2 females) 
 
 
 
 
 
Group I  : control group received  0.2ml of  distilled water orally. 
Group II  : standard received Lonidamine 50mg/kg/rat per day   
Group III  :received  200mg  of body weight of ethanolic extract of Mirabilis jalapa Linn. 
Group IV : received  200mg  and 400mg/kg of body weight of ethanolic extract of Mirabilis 
jalapa Linn. 
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Figure 5.22  Male fertility index(%) 
 
 
 
 
 
 
Group I  : control group received  0.2ml of  distilled water orally. 
Group II  : standard received Lonidamine 50mg/kg/rat per day   
Group III  :received  200mg  of body weight of ethanolic extract of Mirabilis jalapa Linn. 
Group IV : received  200mg  and 400mg/kg of body weight of ethanolic extract of Mirabilis 
jalapaLinn. 
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Table 5.29 Effect of Oral administration of Mirabilis jalapa Linn on Serum Levels of 
AST, ALT, Urea, Creatinine of male rats 
 
Group Doses 
(mg/kg) 
AST(U/L) ALT(U/L) Urea Creatinine 
Control 00 63.48±1.22 134.21±4.21 38.21±1.42 0.36±0.12 
Standard 
(Lonidamine) 
50 62.01±0.10 135.12±0.12 38.42±0.12 0.36±1.12 
EEMJ 200 64.21±1.21 135.01±1.21 38.10±1.12 0.35±0.10 
EEMJ 400 65.21±0.12 136.12±0.12 38.02±0.01 0.36±1.10 
 
 
 
 
 
AST: Aspartate Amino transferase 
ALT Alanine aminotransferase 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 5.23 Effect of Oral administration of 
AST, ALT, U
 
 
 
 
Group I  : control group received  0.2ml of  distilled water orally.
Group II  : standard received Lonidamine 50
Group III  :received  200mg  of body 
Group IV : received  200mg  and 400mg/kg 
jalapaLinn. 
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Figure 5.24 Effect of Oral administration of Mirabilis jalapa Linn on Serum Levels of 
AST, ALT, Urea, Creatinine of male rats 
 
 
 
 
 
 
 
 
 
 
 
 
 
Group I  : control group received  0.2ml of  distilled water orally. 
Group II  : standard received Lonidamine 50mg/kg/rat per day   
Group III  :received  200mg  of body weight of ethanolic extract of Mirabilis jalapa Linn. 
Group IV : received  200mg  and 400mg/kg of body weight of ethanolic extract of Mirabilis 
jalapaLinn. 
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 Table 5.30 Haematological Analysis of male rats after treatment with Ethanolic  
 
Extract of Mirabilis jalapa Linn  
 
 
 
 
Group Doses 
(mg/kg) 
RBC 
(x106/mL) 
Hb(g%) PCV(%) TLC(x103/mL) 
Control 00 8.5±0.12 10.24±0.32 30.12±1.12 11.2±0.12 
Standard 
(Lonidamine) 
50 8.6±0.01 10.34±1.02 31.42±0.06 11.0±1.24 
EEMJ 200 8.5±1.16 10.28±1.14 30.41±1.12 11.12±1.01 
EEMJ 400 8.6±1.04 10.14±0.12 29.42±0.12 11.4±1.10 
 
 
 
Values represent the mean ± S.E. for each group 
No Statistical significance from control  
PCV: Packed Cell Volume; TLC: Total Leucocyte Count 
 
 
 
 
 Figure 5.25 Haematological Analysis of male rats after treatment with 
Ethanolic Extract of Mirabilis jalapa Linn
 
 
 
 
 
 
Group I  : control group received  0.2ml of  distilled w
Group II  : standard received Lonidamine 50
Group III  :received  200mg  of body 
Group IV : received  200mg  and 400mg/kg of body 
jalapa Linn. 
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Figure 5.26 Haematological Analysis of male rats after treatment with 
Ethanolic Extract of Mirabilis jalapa Linn 
 
 
 
 
 
 
 
 
 
Group I  : control group received  0.2ml of  distilled water orally. 
Group II  : standard received Lonidamine 50mg/kg/rat per day   
Group III  :received  200mg  of body weight of ethanolic extract of Mirabilis jalapa Linn. 
Group IV : received  200mg  and 400mg/kg of body weight of ethanolic extract of Mirabilis 
jalapa Linn. 
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Table 5.31 Effect of Mirabilis jalapaLinn on Rat Uterine contractility 
S.No Volume of 
Extract 
Concentration 
Mg/ml 
Log 
Concentration 
Height (cm) % response 
I 0.1 10 1.0 1 24.2 
II 0.2 20 1.301 1.8 43.92 
III 0.4 40 1.602 2 48.8 
IV 0.8 80 1.9030 2.5 78.12 
V 1.6 160 2.2041 3.2 100 
 
Table 5.32 Effect of OxytocinLinn on Rat Uterine contractility 
S.No Volume of 
Extract 
Concentration 
Mg/ml 
Log 
Concentration 
Height (cm) % response 
I 0.1 10 1.0 1.5 33.27 
II 0.2 20 1.301 2.2 48.81 
III 0.4 40 1.602 3.2 71,10 
IV 0.8 80 1.9030 4.0 88.88 
V 1.6 160 2.2041 4.5 100 
 
Table 5.33 Results of Sperm HOS,EY and SCD Tests in Ethanolic Extract of Mirabilis 
jalapaLinn 
 
 
Group 
 
Doses 
(mg/kg) 
Sperm Membrane Changes (%) 
Normal 
HOS 
Abnormal 
HOS 
EY 
Stained 
EY 
Stained 
DNA 
Fragmentation % 
Control 00 70.2±1.4 20.2±1.2 24.2±1.2 72.1±1.2 11.8±1.2 
EEMJ 200 0-* 100-* 100-* 0-* 12.2±0.2 
EEMJ 400 0-* 100-* 100-* 0-* 12.8±1.2 
 
Values are expressed as mean ±S.D. 
P<0.0001 compared with Control 
Statistical Significance was evaluated with Student’s paired t-test 
  
Fig :5.27 Effect of Mirabilis jalapa Linn and Oxytocin 
on Rat Uterine contractility 
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DISCUSSIONS 
 
 
 
 
 
 
 
 
 
 
 
 
VI. DISCUSSION 
Phytochemical investigation of the leaves of mirabilis jalapa in different extracts using acetone 
,ethyl acetate,ethanol and petroleum ether Solvents.  
Acetone extract showed the presence of alkaloids and carbohydrates.Ethyl acetate showed the 
presence of alkaloids ,carbohydrates and glycosidesEthanol extact showed the presence  of 
alkaloids,carbohydrates,saponins,terpenes and tannins.Petroleum ether showed the presence of 
alkaloids.aqueous extract showed the presence of alkaloids ,tannins and carbohydrates.In 
mirabilis jalapa Linn the ethanolic extract showed the highest yield as compared to other 
solvents .Hence ethanolic extract was choosen for pharmacological investigation. 
In acute toxicity studies as per OECD guidelines 423 there were no signs of toxicity upto 
2000mg/kg body weight.(Table 5.2) 
In sub-acute toxicity studies (Repeated 28 days oral toxicity OECD 407 )there was no changes 
in body weight, food intake,water intake physical appearance, Haematological examination, 
biochemical examination,histopathology of vital organs. 
 
In Estrogenic and anti Estrogenic activity, the oral administration of Ethanolic extract of 
Mirabilis jalapa Linn at 400 mg/kg body weight caused a significant increase in Uterine 
weight (P<0.001) as compared to control (Table:5.12)The administration of extract with 
Ethinyl estradiol showed marked increase in Uterine weight as compared to control. The 
Uterotropic changes such as diameter of the Uterus, and the thickness of the 
endometrium(P<0.1) was significantly increased when compared to the control as(5.13) The 
Ethanolic Extract of 400 mg/kg of Mirabilis jalapa Linn induced vaginal opening whereas 
control showed closed vaginal opening (Table 5.12). The number of Cornified cells in the 
Vaginal smears were considerably high(+to ++) in 200 and 400 mg/kg of Ethanolic extract of 
Mirabilis jalapa Linn when compared to control (0 to +). 
In antiovulatory activity,the ethanolic extract showed most effective in interrupting the normal 
estrous cycle of rats.it showed prolonged diestrous stage of the estrous cycle with inhibition of 
ovulation(Table:5.17).The ethanolic extract showed reduced duration of estrous and 
metaestrous phases with prolonged diestrous phase. 
In abortifacient activity ,theethanolic extract was found to exhibit significant pregnancy 
interceptive activity.The administration of 400 mg/kg body weight of the ethanolic extract 
resulted in 100% abortion and 200 mg/kg weight of the ethanolic extract resulted in 43.01% 
abortion. (Table 5.22). In 400 mg/kg body weight of Ethanolic Extract of Mirabilis jalapa Linn 
showed high number of reaabsorption  in individual rats when compared to control. This 
showed decrease in the percentage of lived foetuses. No live fetus were observed at the dose of 
400 mg/kg body weight of ethanolic extract. The percent resorption  index was zero in control 
groups, where as 100% in 400mg/kg of Ethanolic Extract and it showed 43% in 200 mg/kg of 
Ethanolic Extract of Mirabilic jalapa Linn (Table :5.22).  
 
In implantation activity, after treatment with 200 mg and 400 mg/kg body weight of Mirabilis 
jalapa Linn, the body weight were reduced upto 21 days. Maximum reduction in body weight 
as compared to control group. There are rise in body weight in control group(Table 5.14) 
Maximum percent inhibition or reduction was observed in 400 mg/kg of Mirabilis jalapa Linn 
when compared to control. There was a 100% reduction in pregnancy was observed in 400 
mg/kg of Mirabilis jalapa Linn when compared to control. All the rats were delivered in 
control groups. There were no rats delivered in 400 mg/kg of Mirabilis jalapa Linn, where as 
30% of rats delivered in 200 mg/kg of Mirabilis jalapa Linn when compared to control.  
In (Table 5.19)Biochemical changes were observed in Blood Glucose, Cholestrol, triglycerides. 
In 400 mg/kg of Ethanolic Extract of Mirabilis jalapa Linn showed depletion in Blood 
Glucose, Cholestrol, Triglycerides when compared with control. In 200 mg/kg it showed less 
depletion of blood glucose, Cholestrol and Triglycerides when compared with control. 
Reversible anti-fertility activity , it showed no significant change inthe diestrous phase and 
estrous cycle after withdrawing the extract showed the reversible nature of the anti-fertility 
effect of the extract. There was a significant decrease in the duration of proestrus and metastrus 
stage in 200 mg/kg and 400 mg/kg body weight of Mirabilis jalapa Linn when compared with 
the control group. The prolongation of diestrus phase may lower the change of pregnancy.  
In hormonal analysis,the reduction in the concentration of FSH indicates the disturbance in the 
estrus cycle and ovulation.The significant reduction in LH  showed the disturbance in the 
development and  function of corpora lutea. 
The Anti-Fertility in male rats, oral administration of Ethanolic Extract of 200 mg and 400 
mg/kg body weight which showed dose related decrease in the Serum Level of Testosterone, 
Follicle stimulating  hormone (FSH) and Luteinizing hormone (LH) ( Table 5.24-). The Serum 
testosterone level was 2.40 ng/ml in 400 mg and 3.28 ng/ml in 200 mg/kg group, while FSH in 
200 mg/kg and 400 mg/kg wer 5.14mlU/ml and 4.62 mlU/ml in control groups. While Serum 
level of LH was recorded as 0.46mlU/ml and 0.33 mlU/ml in 200 mg/kg and 400 mg/kg 
respectively compare to 0.64 mlU/ml in control group. The serum level of prolactin were in 
1.52 ng/ml and 1.82 ng/ml in 200 mg/kg and 400 mg/kg body weight of Ethanolic Extract of 
Mirabilis jalapa Linn when compared to 0.88 ng/ml of control group. Both extracts 200 mg/kg 
and 400 mg/kg showed significant increase in prolactin when compared to contol group. 
The mortality of caudal epididymal spermatozoa were reduced significantly in 200 mg/kg and 
400 mg/kg of Mirabilis jalapa Linn in a dose-dependent manner as compared to control. Sperm 
mortality were64.2% and 58.8% in 200 mg/kg and 400 mg/kg when compared to control 
89.4%. The sperm count were 34.2x106/ml and 30.4 x 106/ml in 200 mg/kg and 400 mg/kg of 
Mirabilis jalapa Linn when compared to control 50.1x106/ml. There was a significant decrease 
in sperm count and sperm motility in the extracts in a dose dependent manner when compacted 
to control. There was a significant decrease in the percentage of viability 66.2% and 60.4% in 
200 mg/kg and 400 mg/kg when compared to control 84.4% (Table 5.25) 
The fructose concentration in both extracts showed significant decrease (i.e, 2.95µm/ml and 
2.70 µm/ml in 200 mg/kg and 400 mg/kg when compared to control 4.62 µm/ml. The mating 
success of the male rats showed decrease in the percentage of the extracts 75% and 50% when 
compared to control 100%. There was a significant decrease in male fertility index of 200 
mg/kg and 400 mg/kg (85% and 83.3% respectively) when compared to control group. There 
was no significant changes were detected in the serum activity of Alanine amino transferase 
(ALT) and aspartate aminotransferase (AST) of rats. Red blood Cell (RBC) count, 
haemoglobin(Hb) concentration, packed cell volume (PCV) and total Leucocyctoc count(TLC) 
in 200 mg/kg and 400 mg/kg did not show any changes wer compared to no control (Table 
5.31) In vitro studies, after treating with Ethanolic of Mirabilis jalapa Linn sperm membrane 
had changed which was clearly observed under the microscope by using the HOS and EY tests. 
All spermatozoa (100%) treated with extracts were positively stained by EY and tail unswollen 
by HOS. The mean percentage of sperm DNA fragmentation was not significantly different 
among 200 mg/kg and 400 mg/kg extract groups. This indicates that the sperm chromatin is not 
damaged by exposing the extract. 
Invitro uterine contractility of ethanolic extract of mirabilis jalapa Linn when compared with 
oxytocin it produced concentration dependent increase in uterine muscle contraction..thus the 
extract act as a uterine contraction which can be developed as a medicine in future and can be 
use for  induction of labour. 
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VII SUMMARY AND CONCLUSION 
 
Many Contraceptive Methods are used to control population growth and most widely used 
method is Oral Contraceptives. But this has serious side effect. In order to overcome this 
serious side effects there is a need of alternative medicines which has no or minimal side 
effects. One of this is a Traditional Medicine(there is an urgency to meet the requirement of 
safe and active natural contraceptive agents with minimal side effect).These herbal medicines 
are co-friendly and easily available and affordable even in rural areas. These herbs act both in 
males and females in different ways. In Females it prevents Ovulation, it prevent fertilization, 
implantation and also act as abortifacient. In Males, it prevent Spermatogenesis, reduce the 
sperm count and sperm motility, inhibit male hormones. Very few studies have been carried 
out to confirm the safety and efficacy of herbs used as Anti-fertility agents. 
 
Mirabilis jalapa Linn is used for Cytotoxic, Hypo-Glycaemic, Anti-Hyperlipodemia, anti-
nociceptive, anti-Inflammatory, anti-histamine. But there is no scientific evidence for its Anti-
Fertility Efficacy. The study were carried out by using Ethanolic Extract of Mirabilis jalappa 
Linn on male and female of Wistar rats. In female Wistar rats, it prevent Ovulation and 
Implantation and it shows 100% abortifacient activity and also it has reversible anti-fertility 
efficacy. In Anti-Fertility in male Wistar rats it reduces sperm count and sperm motility and 
also reduces hormonal level. So the plant mirabilis jalapa Linn act on both makes and females 
as Anti-fertility Efficacy. 
 
 
 
In the present study, it was concluded that Phyto-chemical analysis of acetone extract showed 
the presence of alkaloids and carbohydrates. Ethyl acetate extract showed the presence of 
alkaloids, carbohydrates and glycosides, petroleum ether extract showed the presence of 
alkaloids and ethanol extract showed the presence of alkaloids, carbohydrate saponins, terpenes 
and tannin. 
In acute toxicity studies, it showed no toxic signs upt to 2000 mg/kg body weight 
In sub-acute toxicity studies, there was change in body weight, no changes in Haematological , 
no changes infood and water intake, no changes in biochemical and histopathological changes. 
In abortifacient activity,the oral administrative of Ethanolic Extract of 200 mg/kg and 400 
mg/kg of Mirabilis jalapa Linn reported abortifacient activity. This abortifacient might be 
mediated through Estrogenic activity. Since estrogen are known to increase Uterine 
contractibility to expel fertilised egg. It also disrupts the functional equilibrium between 
Estrogen and Progesterone. 
In antiovulatory activity,the ethanolic extract showed most effective in interrupting the normal 
estrous cycle of rats.it showed prolonged diestrous stage of the estrous cycle with inhibition of 
ovulation.The ethanolic extract showed reduced duration of estrous and metaestrous phases 
with prolonged diestrous phase.it showed inhibition of ovulation with interrupting  in estrus 
cycle.it showed that this changes in the estrus cycle is by the synthesis of ovarian 
estrogenwhich is governed by pituitary gonadotropins and hypothalamic releasing factor. 
 
In estrogenic and antiestrogenic activity,there was an increased Uterine weight and stimulated 
Uterine growth suggesting Estrogenic activity.It also observed that when ethanolic extract 
given with ethinyl estradiol it suppress the action of ethinyl estradiol.it also showed that the 
ethanolic extract showed significant estrogenic activity when given alone ,but with ethinyl 
estradiol it showed antiestrogenic activity. 
There was a significance increase in uterine weight, diameter of the Uterus, thickness of the 
endometrium and Vaginal cornification when to compared to the  control. 
 
 
 
In implantation activity,In implantation activity, after treatment with 200 mg and 400 mg/kg 
body weight of Mirabilis jalapa Linn, the body weight were reduced upto 21 days. Maximum 
reduction in body weight as compared to control group. There are rise in body weight in 
control groupMaximum percent inhibition or reduction was observed in 400 mg/kg of 
Mirabilis jalapa Linn when compared to control. There was a 100% reduction in pregnancy 
was observed in 400 mg/kg of Mirabilis jalapa Linn when compared to control. All the rats 
were delivered in control groups. There were no rats delivered in 400 mg/kg of Mirabilis 
jalapa Linn, where as 30% of rats delivered in 200 mg/kg of Mirabilis jalapa Linn when 
compared to control 
 In hormonal analysis,the reduction in the concentration of FSH indicates the disturbance in the 
estrus cycle and ovulation.The significant reduction in LH  showed the disturbance in the 
development and  function of corpora lutea.hence the suppressed LH  and increased prolactin 
level is due to prolonged estrus cycle.Inbalance in the endogenous estrous and progesterone  
could be responsible for anti implantation activity. 
Reversible anti-fertility activity , it showed no significant change inthe diestrous phase and 
estrous cycle after withdrawing the extract showed the reversible nature of the anti-fertility 
effect of the extract. 
The Anti-Fertility in male rats, oral administration of Ethanolic Extract of 200 mg and 400 
mg/kg body weight which showed dose related decrease in the Serum Level of Testosterone, 
Follicle stimulating  hormone (FSH) and Luteinizing hormone (LH) 
There was a significant decrease in sperm count and sperm motility in the extracts in a dose 
dependent manner when compacted to control. There was a significant decrease in the 
percentage of viability 66.2% and 60.4% in 200 mg/kg and 400 mg/kg when compared to 
control 84.4%. 
The mortality of caudal epididymal spermatozoa were reduced significantly in 200 mg/kg and 
400 mg/kg of Mirabilis jalapa Linn in a dose-dependent manner as compared to control. 
 
 
 
There was a significant decrease in male fertility index of 200 mg/kg and 400 mg/kg (85% and 
83.3% respectively) when compared to control group. There was no significant changes were 
detected in the serum activity of Alanine amino transferase (ALT) and aspartate 
aminotransferase (AST) of rats. Red blood Cell (RBC) count, haemoglobin(Hb) concentration, 
packed cell volume (PCV) and total Leucocyctoc count(TLC) in 200 mg/kg and 400 mg/kg did 
not show any changes wer compared to no control  
 In vitro studies, after treating with Ethanolic of Mirabilis jalapa Linn sperm membrane had 
changed which was clearly observed under the microscope by using the HOS and EY tests. All 
spermatozoa (100%) treated with extracts were positively stained by EY and tail unswollen by 
HOS. The mean percentage of sperm DNA fragmentation was not significantly different 
among 200 mg/kg and 400 mg/kg extract groups. This indicates that the sperm chromatin is not 
damaged by exposing the extract. 
Invitro uterine contractility of ethanolic extract of mirabilis jalapa Linn when compared with 
oxytocin it produced concentration dependent increase in uterine muscle contraction..thus the 
extract act as a uterine contraction which can be developed as a medicine in future and can be 
use for  induction of labour. 
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 VIII IMPACT OF THE STUDY 
Many Contraceptive Methods are used to control population growth and most widely used 
method is Oral Contraceptives. But oral contraceptives have serious  side effects such as 
intermenstrual spotting,Breast tenderness,weight gain,irregular periods,mood changes 
,decreased libido,menorrhagia,dysmenorrhea endometriosis.there is aa urgency to meet the 
requirements of safe and active natural contraceptive with minimal side effects. 
 
The thesis work reveals that the plant mirabilis jalapa Linn  has antifertility efficacy in both 
male and female albino wistar rats.Particularly it prevents ovulation and implantation and also 
act as an abortifacient in female rats.The study also further reveals that the plant has the   
reversible antifertility efficacy in female rats and it also reduces sperm count, sperm motility in 
male rats.Thus it act as a spermatogenic activity in male rats.  
 
In future, the decoctions of the leaves can be used as “Child Birth Aid” since it has abortificient 
activity, it can be used by Women for abortion or miscarriage in Women. Since the plant 
contracts isolated Uterine muscle of the rat in a concentration dependent manner., it has been 
used to induce delivery in complications(dystocia). 
 
The impact of the research work findings establish a strong  foundation for  the woman to use  
effectively this plant to prevent contraception as traditional infertility medicine. 
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